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RÉSUMÉ 
Les différentes modalités d'imagerie médicales fournissent des images cliniques de structures 
internes du corps humain à des fins diagnostiques et curatives. Leur première application en 
clinique remonte à trois décennies et depuis, grâce aux découvertes technologiques continues, de 
nouvelles fonctionnalités ont été intégrées aux systèmes d'imagerie. Aujourd'hui, des 
informations anatomiques et fonctionnelles précises peuvent être prélevées à partir de ces images 
dont la dimensionnalité a évolué du bidimensionnel au tridimensionnel incluant la dynamique. 
Une des modalités d'imagerie qui a largement profité de ces découvertes technologiques est 
l'imagerie par résonance magnétique (IRM). Par rapport aux autres techniques d'imagerie, l’IRM 
présente beaucoup d’avantages tels que la haute résolution spatiale et temporelle, le manque 
d'exposition aux rayonnements X et une pénétration tissulaire illimitée. Ceux-ci ont rendu l'IRM 
l'une des modalités les plus utilisées en clinique. 
Malgré des améliorations récentes dans le fonctionnement des bobines de réception d'IRM et 
aussi des algorithmes de reconstruction, des progrès supplémentaires sont requis afin d’améliorer 
la visualisation des microstructures en clinique. La visualisation des microvaisseaux avec un 
diamètre de 200 µm, reste au-delà des capacités des modalités d’imageries cliniques actuelles. 
 Dans le traitement du cancer, une telle capacité pourrait fournir les informations nécessaires 
pour les nouvelles méthodes de délivrance ciblée de médicaments comme la navigation par 
résonance magnétique (NRM). Dans cette technique, afin d'améliorer l'indice thérapeutique, les 
microporteurs, chargés avec des agents thérapeutiques et des particules magnétiques, sont guidés 
le long d'une trajectoire qui mènerait vers une zone cancéreuse. Notre objectif est de telle 
trajectoire qui débuterait du bout du cathéter d'injection jusqu'à la destination finale, soit à 
proximité d’une zone tumorale. 
Le contraste de susceptibilité magnétique dans l'IRM fournit un moyen pour prononcer l'effet 
d'une particule magnétique même si sa taille est beaucoup plus petite que la résolution spatiale de 
l'IRM. En raison de leur susceptibilité magnétique élevée, les matériaux magnétiques provoquent 
une inhomogénéité dans le champ magnétique local de l'IRM dans une mesure beaucoup plus 
importante que leur taille réelle. L’inhomogénéité apparaît dans les images de gradient écho 
pondéré en T2* sous forme d'une perte de signal. Cette approche présente un moyen de 
visualisation de microstructures en exploitant leur artefact de susceptibilité. 
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L'artefact de susceptibilité (perte de signal) a d'abord été caractérisé par des expériences de 
simulation sur les fantômes. L’étendue de l'artefact de susceptibilité s’est avérée corrélée avec la 
durée d'écho, le champ magnétique statique, la taille des particules et leur magnétisation à la 
saturation. Selon le temps d'écho, l’étendue de l'artefact est 75 à 146 fois et de 72 à 135 fois plus 
grande que la taille réelle de la particule à 3,0 T et à 1,5 T, respectivement. 
Des particules magnétiques d’une taille micrométrique à forte aimantation sont classées 
comme matériaux ferromagnétiques. En raison de la magnétisation rémanente, l'utilisation de 
telles particules est limitée en clinique. Comme étape suivante, l'utilisation des agglomérations 
micrométriques, composées de nanoparticules superparamagnétiques, en tant qu'agents de 
contraste en IRM a été étudiée. Les agglomérations peuvent reproduire le comportement de 
microparticules magnétiques en termes d’artefact de susceptibilité dans une image. Les 
agglomérations ont été générées en utilisant une puce microfluidique en jonction-T. Un 
ferrofluide à base d'huile a été utilisé pour générer les gouttelettes d’huile dans l'eau. L'avantage 
d'utiliser un dispositif microfluidique est le contrôle précis de la taille des gouttelettes ainsi que 
leur espacement. Les microagglomérations de nanoparticules d'oxyde de fer ont été injectées dans 
des microcanaux de 200 µm et 50 µm de diamètre interne, respectivement. Les diamètres choisis 
sont dans l'échelle d'une grande et une petite artériole. Les résultats ont montré que les 
agglomérations de 50 µm de diamètre sont juste visibles dans les images d’une séquence d’écho 
de gradient rapide (TrueFISP). 
Par la suite, on a étudié la précision de positionnement des particules à partir de leur effet de 
susceptibilité sur les images. Les images reconstruites contiennent deux types d'artefacts en 
présence de matériaux magnétiques: la distorsion géométrique et le déplacement d'écho. La 
première distorsion mène à un défaut d'alignement de la position des protons tandis que la 
seconde distorsion provoque une perte de signal sous forme d'une "trèfle à quatre feuilles" sur les 
plans frontal et sagittal et un cercle sur le plan transversal. Le déplacement d'écho génère une 
perte de signal d’une forme symétrique dont l’origine peut représenter la position de la particule. 
La distorsion géométrique déplace le centre de l'artefact et peut mener à une erreur de calcul de la 
position de la particule. Il a été montré que le déplacement d'écho est l'effet dominant sur la 
distorsion géométrique dans les séquences de gradient d’écho. Alors, la position des particules a 
été déterminée en se basant sur leur centre de gravité. L'erreur moyenne a été calculée et elle est 
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environ la moitié de la taille d'un pixel. L'analyse de la dispersion a confirmé la reproductibilité 
des résultats. 
A l'étape suivante, un réseau vasculaire 2D comprenant un canal d'entrée se diversifiant en huit 
canaux plus petits, en trois étapes, avec un diamètre interne de 150 µm au dernier niveau a été 
reconstruit. Les microagglomerations de nanoparticules d'oxyde de fer (150 ± 20 µM) ont été 
injectées dans un réseau vasculaire fabriqué en plexiglas en utilisant une machine de micro-
usinage. Une séquence rapide multi-shot et sensible à la susceptibilité magnétique (TrueFISP) a 
été utilisée pour suivre les particules pendant leur injection dans le réseau. L'expérience a été 
répétée deux fois. La première et la deuxième expérience ont donné 70 et 114 images, 
respectivement. Les pertes de signal ont été identifiées visuellement et positionnées à travers leur 
centre de gravité. Toutes les positions ont été assemblées pour constituer la trajectoire des 
particules. Les résultats suggèrent que la technique peut être utilisée pour un suivi en temps réel 
des particules magnétiques pour regrouper les images d'un vaisseau sanguin qui est au-delà de la 
résolution d’un système IRM clinique. 
Afin d’étendre l'approche d'une représentation 2D à 3D, nous avons proposé un nouvel 
algorithme basé sur la séquence TrueFISP de multi-shot et multi-tranche. La technique a été 
validée à l’aide d’un réseau 3D en verre. Les microagglomerations ont été injectées dans le 
réseau et ont été suivies dans différentes coupes. Le temps d'acquisition par coupe était de 0.6 s. 
L'erreur de reconstruction était plus élevée dans certains segments du réseau vasculaire. Ceci a 
été imposé par la limitation dans la diminution de l'épaisseur de coupe à cause de la dégradation 
du rapport signal sur bruit. L'erreur de mesure moyenne a été évaluée à ~ 0.4 mm. 
Dans NRM, la représentation 3D des trajectoires de particules est une étape importante dans 
l'identification du réseau vasculaire menant au site de la tumeur. En raison de la résolution 
spatiale limitée des scanners d'IRM cliniques actuels, un positionnement précis des particules 
n’est pas possible. Cependant, le contraste de susceptibilité qui se présente dans les séquences à 
la base de gradient d’écho peut donner un aperçu sur la façon dont les particules sont réparties 
dans le champ de vision.  
En conclusion, ce projet propose une nouvelle technique fiable dans la visualisation des 
microvaisseaux chez l’humain en utilisant un IRM clinique et les bobines réceptrices 
commerciales. Ceci est une étape importante dans le ciblage des tumeurs en utilisant NRM. Le 
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suivi en temps réel des microagglomerations d'oxyde de fer mène à obtenir leur trajectoires de 
mouvement et les trajectoires mènent à une représentation 3D de la microvasculatures dans le 
corps humain qui n’est pas visibles à l'aide des modalités d’imageries cliniques actuelles. Les 
expériences in vivo restent pour valider l'application clinique de la technique proposée dans le 
cadre des futurs travaux. La carte 3D de la microvasculature alimentant un site tumoral mène à 
une amélioration significative de l'efficacité du ciblage de la tumeur en NRM tout en réduisant 
les effets secondaires de la chimiothérapie, le risque de reformage à la tumeur et des métastases 
aux autres organes. 
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ABSTRACT 
Medical imaging modalities strive to provide clinical images of the human body’s internal 
structures for diagnosis and treatment purposes. Their first application in clinical trial services 
goes back to three decades and owing to continuous technological inventions, new capabilities 
have ever since been incorporated into the imaging systems. Today, anatomical and functional 
data with finer details and larger image sizes can be achieved and dimensionality of the images 
has been increased from 2D to dynamic 3D fields. One of the imaging modalities that have 
probably profited the most from technological findings is the magnetic resonance imaging (MRI). 
Compared to the other imaging techniques, MRI has various advantages such as high spatial and 
temporal resolution, lack of radiation exposure and unlimited tissue penetration. These have 
turned the MRI to one of the most available modalities clinically.  
Despite recent improvements in the MRI’s receiver coils and reconstruction algorithms, further 
progress is yet sought to improve the visualization of the microstructures using the clinical MR 
scanners. Visualization of microvessels with an inner overall cross-sectional area of 
approximately less than 200 µm, remains beyond capabilities of the current clinical imaging 
modalities. In cancer therapy, such capability would provide the information required for the new 
delivery methods such as magnetic resonance navigation (MRN). In the MRN, to enhance the 
therapeutic index, microcarriers loaded with therapeutic agents and magnetic particles are 
navigated along a planned trajectory in the vicinity of the treatment region. Our objective is to 
provide such a trajectory map within an area covering the location of the catheter tip for the 
injection site up to the extremity of the particles’ path i.e. vicinity of the treatment region such as 
a tumor site.  
Susceptibility-based negative contrast in the MRI provides a way to enlarge the effect of a 
magnetic particle whereas its actual size is much smaller than the MRI’s visualization capability. 
Due to their high magnetic susceptibility, magnetic materials cause an inhomogeneity in the local 
magnetic field of the MRI to an extent which is much larger than their actual size. The 
inhomogeneity appears in the T2*-weighed gradient echo images in the form of a signal void. 
This approach presents a method for visualization of microstructures through the susceptibility 
artifact. 
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The susceptibility artifact (signal void) was initially characterized through simulation and 
phantom experiments. The extent of the susceptibility artifact was found to be related to the echo 
time, static magnetic field, particle’s size and saturation magnetization. Depending on the echo 
time, the extent of the artifact is 75 to 146 times and 72 to 135 times larger than the particle’s 
actual size at a 3.0 T and a 1.5 T magnetic field, respectively.  
Micron-sized magnetic particles with high magnetizations within the susceptibility spectrum 
are categorized as ferromagnetic materials. Due to the remanent magnetization, application of 
such particles is limited to clinical trials. As the next step, application of micron-sized 
agglomerations of superparamagnetic nanoparticles as contrast agents in the MRI was studied. 
Agglomerations can resemble the signal loss behavior of the microparticles in an image. The 
agglomerations were generated using a T-junction microfluidic chip. An oil-based ferrofluid was 
applied to generate oil in water droplets. The advantage of using a microfluidic device is the 
precise control over the size of the droplets as well as their spacing. Microagglomerations of iron-
oxide nanoparticles were injected in microchannels of 200 µm and 50 µm in internal diameter 
respectively. The selected diameters are well in the scale of a large, and a small arteriole. The 
results showed that agglomerations of 50 µm in diameter are just visible in the images of a fast 
gradient echo sequence (TrueFISP).  
Subsequently, the accuracy of particle positioning using their effect on the images was 
investigated. The reconstructed images are subject to two types of artifacts in the presence of 
magnetic materials: geometrical distortion and echo shifting. The former leads to a 
misregistration of the spins’ position while the latter causes a signal loss in the form of a four-
leaf-clover on the coronal and sagittal planes and a circle on the transversal plane. The echo 
shifting generates symmetric signal loss shapes the centers of which can represent the origin of 
the artifact and thus the position of the particle. On the other hand, the geometrical distortion 
displaces the center of the artifact and can lead to a miscalculation of the particle’s position. It 
was shown that the echo shifting is the dominant effect over the geometrical distortion. Position 
of the particles was determined based on their center of gravity. The average error was calculated 
to be approximately half of a pixel’s size. The variation analysis of the results confirmed the 
reproducibility of the results. 
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At the next step, a 2D vascular network including an inlet channel branching into eight smaller 
channels in a three-stage division with an inner diameter of 150 µm at the last level was 
reconstructed. Microagglomerations of iron oxide nanoparticles (150 ± 20 µm) were injected in a 
vascular network made of Plexiglas using a micro-milling machine and the high-pressure thermal 
sealing technique. A fast multi-shot susceptibility sensitive sequence (True-FISP) was used to 
track the particles as they were injected in the network. The experiment was repeated twice. The 
first and the second trials yielded 70 and 114 images, respectively. The signal voids were 
identified visually and positioned through their center of gravity. All the positions were 
assembled to build up the trajectory of the particles. The results suggested that the technique can 
be used through a real-time tracking of the magnetic particles to gather images of a blood vessel 
which is beyond the resolution of the scanner.  
In order to expand the approach from a 2D to a 3D representation of the vascular network, we 
proposed a new algorithm based on a fast multi-shot, multi-slice susceptibility sensitive MR 
sequence. The technique was validated through phantom studies in a 3D network made of glass. 
Microagglomerations of iron-oxide nanoparticles were injected in the network and tracked in 
different imaging slices. The acquisition time per slice was 0.6 s. The reconstruction error was 
found to be higher in some segments of the vascular network. This was realized to be due to a 
limitation in decreasing the slice thickness and the loss of signal to noise ratio. The mean 
measurement error was calculated at ~ 0.4 mm. 
In MRN, 3D representation of the particles' trajectories is an important step in identification of 
the vascular network leading to the tumor site. Due to the limited spatial resolution of the current 
clinical MR scanners, a precise positioning of the particles is not possible. However, the signal 
loss artifact in the GRE-based sequences can shed light on how the particles are distributed 
within the field of view.  
In conclusion, this project proposes a new and reliable technique for visualization of human 
microvessels using a clinical MR scanner and commercial receiver coils. This will be an 
important step in tumor targeting using the MRN. Real-time tracking of microagglomerations of 
iron oxide nanoparticles can obtain their movement trajectory. Combination of such trajectories 
provides a 3D representation of the microvasculatures within the human body, not visible using 
the current clinical imaging modalities. In-vivo experiments remain as a future work to validate 
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clinical application of the proposed technique. Map of the local micro vasculature feeding a 
tumor site in MRN-assisted chemoembolization intervention, leads to a significant improvement 
on the efficiency of tumor targeting while reducing side effects of chemotherapy, risk of tumor 
reformation and metastases to the other organs.  
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CHAPTER 1  INTRODUCTION 
Cancer is a major chronic disease and a leading cause of mortality in Canada and around the 
world. Depending on type, number, location and stage of the cancerous tumors, one treatment 
option or a combination of different type of treatments may be considered. Palliative treatments 
prevent or slow the development of the cancer cells. In contrast, curative treatments seek to 
achieve a complete removal of cancer cells.  
Surgery is a conventional therapeutic choice for localized and small cancer tumors. It is a 
curative approach to achieve a complete tumor resection or replacement [1]. It can be used alone 
or along with a complementary method such as chemotherapy or radiation therapy [2]. It can also 
be complemented by radiation therapy during the operation.  
Radiation therapy uses high-energy radiations such as X-ray, gamma ray or protons to kill 
cancer cells through damaging their DNA. It can be performed locally or systematically and can 
be used before or after surgery to enhance or complete the main treatment. Due to the limitation 
on the radiation dose, this palliative technique is usually performed as a complementary treatment 
[3, 4]. 
Chemotherapy is a systemic palliative treatment that uses medicines to kill cancer cells. 
Medication can be received orally, intravenously or intra-arterially. During chemotherapy, drugs 
travel throughout the whole body to reach cancer cells. However, healthy cells are inevitably 
damaged as well. Chemotherapy is often prescribed as a complementary treatment after the 
surgery or radiation therapy to kill the remaining cancer cells or before the main treatment to 
shrink the tumors [5, 6].  
Chemoembolization is a combination of chemotherapy and embolization procedure mostly 
used in the liver treatment. In this method drugs are intra arterially injected into the blood vessel 
supplying the tumor. Subsequently, embolic agents are released to embolize the vessel’s entry 
and trap the drugs in the tumor by ceasing the blood supply [7, 8]. Accordingly, a highly 
concentrated dose of therapeutic agents are delivered to the tumor site and the feeding blood 
vessels are partially occluded to starve the tumor of nutrients.  
Targeted therapy is a fairly new type of treatment developed to attack cancer cells with reduced 
harm to the healthy tissue. In this technique drugs or other substances are applied that interfere 
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with specific molecules involved in either growth or survival of the cancer cells. Targeted 
therapies are based on interactions with mediators capable of ceasing the development of 
cancerous tissue. Depending on the type of cancer, targeted therapy can be achieved through 
interference with the development of angiogenesis, prevention of cell growth signaling, 
stimulation of the immune system to destroy cancer cells or specific delivery of therapeutic 
agents to the cancer cells [9-11]. 
 Magnetic resonance navigation (MRN) assisted chemoembolization has been proposed to 
overcome the drawbacks of older interventions. It has shown a great potential in targeted delivery 
of magnetic carriers loaded with therapeutic agents [12, 13]. The technique is based on 
therapeutic magnetic micro carriers (TMMC) which can be steered and tracked using an 
upgraded magnetic resonance imaging (MRI) system.  
TMMC consists of biodegradable microparticles encapsulating magnetic nanoparticles and the 
antitumor drug. They measure 50 µm in diameter. The external magnetic field of the MRI (B0) 
magnetizes the microparticles to saturation. The catheter tip can only be advanced to the level of 
the arteries. However, the tumor is located at the capillary level. Upon the release of the TMMCs, 
custom gradient coils are applied to induce a directional propulsion force on nanoparticles, 
embedded in the micro carriers. This technique leads to the controlled delivery of the therapeutic 
agents to the region of interest. In vivo targeting of the right or left liver lobes has been 
successfully achieved by MRN through the hepatic artery in a rabbit model [12]. The steering has 
been performed through a single bifurcation. However, steering through multiple bifurcations 
necessitates a precise map of the vasculature leading to the tumor. The gradient coils are applied 
according to a 3D pre-planned map of the local vasculature feeding the cancer tumor. 
Consequently, preparation of such a map is an essential step in this intervention. Current clinical 
imaging modalities are limited in resolving the vasculatures smaller than approximately 200 µm 
in diameter. As such, the visualization of arterioles and capillaries remain beyond the capability 
of current clinical imaging modalities.  
This research study seeks to develop a clinical imaging technique to identify the vascular path 
leading to a tumor site with the purpose of improving the MRN technique. The development of 
such a map leads to steer the TMMCs through multiple bifurcations in the vascular network, 
enhancing the steering efficiency and reducing the side effects of the anti-cancer medications.  
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 This thesis is presented in the format of an article-based thesis. The rest is organized in eight 
chapters. Chapter 2 presents a background on MR imaging and a relevant literature review on 
microvascular imaging. Chapter 3 discusses the assumptions and objectives of the thesis and the 
overall approach adopted to accomplish each objective. Chapters 4, 5 and 6 are devoted to 
original contributions of this thesis, corresponding to three articles published or submitted to 
peer-review journals. Chapter 4 includes the article accepted in March 2013 to be published in 
the «Journal of Applied Physics». It represents the visualization of microchannels measuring 50 
µm in diameter, corresponding to small arterioles, using superparamagnetic iron oxide 
nanoparticles and a clinical MR scanner. Chapter 5 includes the article accepted in May 2014 for 
publication in the journal of «Applied Physics Letters» and it represents dynamic tracking of 
magnetic nanoparticles clusters for mapping microvascular networks. Chapter 6 includes an 
article on proposing and validating a method for 3D mapping of vascular network through a fast 
multi-slice multi-acquisition MR sequence. The article was submitted in October 2014 to the 
Journal of «IEEE Transactions on Biomedical Engineering». Chapter 7 presents a new technique 
developed for fabrication of an integrated microfluidic device to generate and inject iron oxide 
microagglomerations in a vascular network. Chapter 8 provides a discussion on all the work 
carried out during this research study. Finally, the conclusion discusses the contributions of this 
thesis and new avenues of research and recommendations for future works are also proposed. 
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CHAPTER 2 LITERATURE REVIEW 
2.1 Magnetic resonance navigation (MRN) 
Navigation of an untethered device in a living subject is of great interest for both therapeutic 
and diagnostic purposes. MRN is a newly developed approach to navigate an untethered micro 
device to a targeted location within the body accessible through the vascular network [14, 15]. 
The extremity of the catheter injecting therapeutic agents can only be advanced to the arterial 
level whereas tumors are often located at the capillary level (figure 2-1).  
 
Figure 2-1: Sketch of MRI targeting of a tumor site by applying a magnetic force on volumes 
loaded with therapeutic agents and magnetic particles. 
 
Therefore, a significant portion of the injected drug reaches the systemic circulation. In MRN, 
micro carriers loaded with therapeutic agents and magnetic particles are released and 
subsequently steering gradients are applied to navigate the carriers towards a selected capillary 
entry where the tumor is located (figure 2-2). 
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 In [16], propulsion of a magnetic core in the carotid artery of a living swine showed feasibility 
of the technique in-vivo. Three orthogonal gradient coils inside a magnetic resonance imaging 
(MRI) scanner can induce a three dimensional directional magnetic force on a magnetic object. 
The magnetic force (Fmag) is proportional to the amplitude of the gradient vector and the 
magnetic moment of the object according to: 
( )BMRVFmag ∇⋅=
!
         (Eq. 2-1) 
where R is the duty cycle of the gradient, V and M
!
 are the volume and the magnetization of the 
magnetic object, respectively, B
!
 is the magnetic field and ∇ the vector differential operator. 
 In order to propel a magnetic object in the vascular network, the magnetic force should 
surmount the drag force applied by the flow. The weight of the magnetic object and its buoyancy 
can be neglected in small blood vessels since such parameters are smaller than the drag force by 
several orders of magnitude. Therefore, to achieve a strong magnetic force, magnetization of the 
magnetic object and the magnetic field gradient generated by the gradient coils should be 
maximized. In [17], a proportional-integral-derivative controller was used to navigate a 
ferromagnetic core along a predefined trajectory in real time. Operating inside an MRI system 
prevents simultaneous application of propulsion and tracking using MR images. Real-time 
tracking necessitated an alternation between these two processes. An advanced MR sequence 
based on magnetic signature selective excitation was developed and employed for fast tracking of 
a single magnetic object [18, 19].  
Clinical MRI systems are typically capable of providing tens of mT/m of gradient in any 
direction. Such gradients are potentially capable of providing enough force to propel a 
ferromagnetic core, saturated in the magnetic field of an MRI, with a diameter of ~0.6 mm [14]. 
However, gradient amplitudes of several T/m would be required to propel a smaller 
ferromagnetic core or in smaller vascular networks. Compared to their ferromagnetic 
counterparts, superparamagnetic particles that are vastly used as contrast agents in MRI hold a 
significantly smaller magnetization. However, an agglomeration of such nanoparticles can be 
used as a steerable magnetic volume for therapeutic purposes. Their relative low magnetization 
should be compensated by application of higher gradient amplitudes. 
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In [13], therapeutic magnetic micro carriers (TMMC) were guided in real time in a phantom 
including a single bifurcation using magnetic gradients of 400 mT/m. TMMC were 
biodegradable microparticles loaded with iron cobalt nanoparticles. These particles possess a 
high saturation magnetization (72 emu/g) and therefore are an excellent candidate for both 
imaging and navigation purposes. Subsequently, TMMC particles loaded with doxorubicin were 
steered in-vivo to the left liver lobes through one bifurcation in a rabbit model using a clinical 
MR scanner equipped with upgraded gradient coils of 400 mT/m [12, 20]. Results suggested the 
potential of MRN for improving drug targeting in deep tissues.  
In-vivo and in-vitro experiments have been performed to confirm the effectiveness of MRN in 
targeted drug delivery. Thus far, navigation of micro carriers has been carried out in-vivo through 
a single bifurcation and in-vitro inside a three bifurcation PMMA phantom [21]. However, the 
ultimate goal in MRN is to navigate microcarriers in-vivo through a vascular network of multiple 
bifurcation levels to the entry of a selected capillary. The direction and the time at which the 
magnetic gradients are applied depend on the local vasculature’s map feeding the tumor. As such, 
preparation of a 3D map of the microvasculature prior to the intervention is a crucial step in 
MRN. 
 
Figure 2-2: A vascular network and relative vessel diameters.  
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Current clinical angiography modalities can help to provide such a map. In section 2.3, the 
visualization of the vascular network using current clinical imaging modalities will be discussed.  
2.2 Magnetic resonance imaging  
MRI uses strong magnetic field and radio frequency waves to generate cross sectional images 
of internal structures of the body. This technique has profited from technological innovations to 
improve quality of the images as well as the acquisition speed. Subjected to a large magnetic 
field (B0), Hydrogen atoms (protons) become aligned with the direction of the field. By applying 
a properly tuned radio frequency, protons will be tipped out of alignment with B0. Upon removal 
of the radio wave, the protons tend to return to their equilibrium state in a process called 
relaxation. The relaxation causes variations in transverse magnetization vector that causes a small 
alteration in the induced electrical current in the receiver coil. The signal is quite sensitive to 
differences in proton content which is a distinctive characteristic of different types of tissue. 
Each MR sequence is a combination of magnetic gradients and radio frequency waves. 
Frequency encoding gradient encodes nuclear magnetic resonance (NMR) signal spatially by 
assigning a unique frequency to the spins at different locations along its direction. Therefore, the 
time-varying NMR signal consists of a range of frequencies, each corresponding to a particular 
spatial location. The range of frequency precession (Δω) along the x-direction (Δx) where Gx is 
applied can be calculated according to: 
xGxΔ=Δ π
γ
ω
2
         (Eq. 2-2) 
where γ is the gyromagnetic ratio of the protons (42.56 MHz/T). A Fourier transform of the NMR 
signal reveals the density of spins at each frequency. A frequency-encoding gradient can be 
applied along any physical direction. It consists of two lobes; prephasing (or dephasing) lobe and 
readout (or rephasing) lobe. The prephasing lobe prepares the transverse magnetization so that an 
echo can be formed later in time. In spin echo (SE) sequences, the two lobes are separated by a 
180˚ refocusing pulse. Since the refocusing pulse inverses the accumulated phase during the 
prephasing lobe, the readout lobe has the same polarity as the prephasing lobe (in order that the 
spins continue to accumulate phase in the same direction).  
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Due to the absence of a 180˚ refocusing pulse, in gradient echo (GRE) sequences the readout 
lobe is reversed to change the direction of the spin’s phase accumulation. The gradient reversal 
refocuses only the spins dephased by the action of the pre-phasing gradient lobe. Therefore, as 
opposed to a SE, phase dispersions resulting from magnetic field inhomogeneities, chemical 
shifts or susceptibility gradients are not cancelled at the center of the GRE (figure 2-3). The time 
between the application of the radio frequency (RF) excitation pulse and the peak of 
the echo signal is known as echo time (TE). The time between the successive excitation pulses is 
known as repetition time (TR). 
 
Figure 2-3: Rephasing mechanism in spin echo sequence (top) and gradient echo sequence 
(bottom) using RF pulses and magnetic gradients. 
 
Peak of the gradient echo occurs when the area under the two opposing lobes is equal. 
Consequently, GRE images are weighted by a factor of exp −TE T2*( )  versus exp −TE T2( )  in SE 
images. The parameter T2* is related to the intrinsic relaxation time of the tissue (T2) by: 
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1
T *2
=
1
T2
+
1
!T2
         (Eq. 2-3) 
where T´2 is inversely proportional to the magnetic field inhomogeneity in each image voxel.  
In-plane spatial localization necessitates the employment of both frequency and phase 
encoding gradients. Phase encoding gradient is typically applied orthogonal to the frequency 
encoding direction. It is applied when the magnetization is in the transverse plane and prior to the 
application of the readout gradient. The area under the phase encoding gradient varies at each TR 
to introduce different amount of phase variations to the spins along its direction.  
In order to achieve a desired spatial location in a 3D volume, slice selection gradients are 
applied concurrently with the RF pulses. The slice selection gradient determines the direction 
perpendicular to the imaging plane (figure 2-4).  
 
Figure 2-4: Spin echo sequence (left) versus gradient echo sequence (right). 
 
GRE sequences can be fast as no refocusing pulse is present and subsequently no long-lasting 
T1 recovery time is required.  
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2.2.1 Magnetic particles in MRI 
 Magnetic nanoparticles have been widely investigated in biomedical applications such as 
hyperthermia, targeted drug delivery and contrast agents in MRI and dual-modality imaging [22-
27]. MRI provides an excellent soft tissue contrast whereas its inherent low sensitivity does not 
convene the visualization of the microstructures. To enhance its sensitivity, contrast agents are 
applied. Contrast agents are categorized into a) gadolinium-based paramagnetic agents and b) 
superparamagnetic nanoparticles. Due to a lower magnetization saturation, gadolinium-based 
contrast agents have a lower sensitivity compared to that of their superparamagnetic counterparts 
[28]. Free gadolinium ions have a toxic effect that can be nephritic [29, 30]. Iron oxide 
nanoparticles have shown a superior biocompatibility and biodegradability [31]. Injected iron 
oxide nanoparticles are cleared through the macrophage process in the reticuloendothelial system 
and subsequently degraded in the lysosomes. 
2.2.1.1 Paramagnetism versus superparamagnetism 
Paramagnetism is the characteristic of the atoms or ions with an unpaired number of electrons 
in their outer shell. As such, these individual atoms or ions possess intrinsic magnetic dipole 
moments. However, due to the random orientation of the individual magnetic dipole moments, an 
agglomeration of them does not reveal any magnetization property. Once subjected to an external 
magnetic field, individual atoms orient along the direction of the magnetic field. Upon removal of 
the applied magnetic field, all the individual atoms return to their original orientation. Due to 
thermal agitation, not all the individual paramagnetic atoms can be aligned with the magnetic 
field unless they are subjected to temperatures of near absolute zero (-273˚C). Gadolinium (Gd3+) 
is one of the strongest paramagnetic substances widely used as MR contrast agents. 
 Unlike paramagnetism which is the property of the individual atoms and ions, ferromagnetism 
is the property of a group of atoms, ions or molecules in a solid crystal. Ferromagnetic materials 
possess multiple domains with random orientations due to which they do not show any 
magnetization property. Once subjected to an external magnetic field, all the individual domains 
orient parallel to the direction of the magnetic field. As opposed to paramagnetic materials, 
ferromagnetic materials can become fully magnetized at practically obtainable field strengths and 
room temperatures. Upon removal of the magnetic field, the individual domains maintain their 
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orientation parallel to the magnetic field. This effect is due to the fact that parallel alignment is a 
preferred low-energy state and thus some energy is required to demagnetize the ferromagnetic 
materials. It is possible to obtain a single magnetic domain particle by decreasing size of the 
multi-domain particles to approximately that of the nanometer sized agents. These single-domain 
nanoparticles are called superparamagnetics having unique magnetic properties. Similar to the 
ferromagnetic particles, they can become magnetized to saturation even at a low magnetic field 
and like the paramagnetic particles they will not retain any net magnetization property in the 
absence of an external magnetic field. The size of the individual magnetic domains depends on 
the magnetic anisotropy and is in the order of tens of nanometers. A transition from multi domain 
structure to single domain structure occurs with the reduction of the particles size to ~ 40 nm. 
This transition is accompanied by a significant reduction in the saturation magnetization [32].  
2.2.1.2 Superparamagnetic iron oxide nanoparticles 
Superparamagnetic iron oxide (SPIO) contrast agents are based on water insoluble iron oxide 
crystals of Fe3O4 (magnetite) or γ-Fe2O3 (maghemite) with a core diameter in the range of 4 - 12 
nm. However, the overall diameter of these particles is considerably larger than their core size (5 
nm - 1µm). The iron oxide particles are coated with an organic polymer to prevent their 
aggregation [33, 34]. The principal effect of the SPIOs is on the T2* relaxation time. MR imaging 
of such nanoparticles is usually performed using the T2*/T2-weighted imaging sequences. The T1 
relaxation time is also affected by the SPIOs enabling the T1-weighted imaging with a less 
pronounced positive T1- contrast [35]. Depending on the distribution of the particles’ size and 
their overall diameter, iron oxide contrast agents are divided into three groups; a) standard SPIO 
agents, ultra small SPIOs (USPIO) and monocrystalline iron oxide nanoparticles (MION). 
Several parameters, such as size and coating and concentration of the particles within an imaging 
voxel, affect the relaxometric behavior of the SPIOs. 
Standard SPIOs have a high T2/T1 relativity ratio and their overall size varies in the range of 60 
-150 nm. They are composed of agglomerated iron oxide cores and in the presence of a magnetic 
field can get separated from the solution. Intravenously injected SPIOs are easily sequestered by 
the reticuloendothelial system (RES) cells in the liver, spleen and bone marrow (half-life, 3 days) 
[36].  
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The USPIOs have a smaller hydrodynamic diameter (10 – 50 nm) and a longer half-life. Owing 
to their small size, Brownian motion keeps them suspended in water in spite of their higher 
density. These agents can cross the capillary wall and spread to the tissue. Due to their long blood 
half-life, they can be used as blood pool contrast agents in the MR angiography [37, 38].  
 The MIONs are very small in size (2 – 9 nm) and are usually used for receptor-directed and 
magnetically labeled cell probe MR imaging [39, 40]. Their core contains one central Iron oxide 
particle only and due to their small size they easily pass through the capillary endothelium.  
 Contrast agents are used to enhance the sensitivity of the MRI through shortening the T1 and 
T2 relaxation times. The efficiency of a contrast agent is evaluated by the relaxivity (r1, r2 and r2*, 
inverse T1, T2 and T2* respectively). R2* relaxivity indicates an increase in the T2 relaxation time 
in the GRE sequences due to a magnetic inhomogeneity called the susceptibility effect: 
R2* = R2 +γBs          (Eq. 2-4) 
where γBs  represents the relaxation induced by the magnetic inhomogeneity. The term 
susceptibility effect describes an increase in the T2/T2* relaxation rates due to a difference in 
magnetization within a voxel. Non-homogeneous distribution of magnetic particles induces a 
local field gradient which causes the spins to lose coherence at an accelerating rate. The 
susceptibility-induced relaxation can affect the protons located much farther from the magnetic 
cores. On the other hand, a homogeneous or dispersed distribution of the magnetic particles 
results in another contrast mechanism where because of a free water access to the contrast agent 
sites, the proton relaxation is due to an interaction between each of the individual magnetic 
particles and water molecules (figure 2-5).  
Two SPIO-based contrast agents are clinically approved: ferumoxides (Feridex in the USA, 
Endorem in Europe, diameter of 120 to 180 nm) and ferucarbotran (Resovist, diameter of 60 nm). 
2.2.1.3 Clusters of magnetic nanoparticles 
An assembly of magnetic nanoparticles can be used to further enhance the contrast. 
Agglomerations of magnetic nanoparticles significantly affect the transverse magnetization [27]. 
It was shown that the sensitivity of MRI is comparable to the one of PET in detecting single cells 
using an assembly of SPIO nanoparticles [41]. 
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Figure 2-5: Dispersed distribution of magnetic particles compared to clusters of magnetic 
particles. 
The R2 relaxivity rate increases with the agglomeration’s size, reaches a maximum and 
decreases subsequently. On the other hand, the r1 relaxivity is only slightly affected by the size of 
the agglomerations [42-45]. Compared to the large agglomerations of the magnetic nanoparticles, 
free magnetic particles show a different contrast mechanism. Since diffusion of the magnetic 
particles is dependent on their size, different mechanisms can be defined based on the translation 
diffusion time around the nanoparticles agglomerations. The diffusion time is defined as: 
τ D =
r2
D
         (Eq. 2-5) 
where r is the radius of the nanoparticles or the agglomerations, and D is the diffusion coefficient 
of the water molecules. The diffusion time is the time for a water molecule to pass a hemisphere 
of a nanoparticle or an agglomeration. 
There are two spin dephasing regimes: the motional averaging regime (MAR) where the water 
diffusion is the main factor in spin dephasing and the static dephasing regime (SDR) where the 
relaxation rate is independent of diffusion. For short diffusion times ( rD wΔ<<1τ where Δwr  is 
the difference in the angular frequency experienced by a proton between the local fields) the 
particles are homogeneously dispersed in the solution. In MAR, the diffusion time is much 
smaller than the echo time and no difference is observed between the r2 and r2* relaxation rates 
(figure 2-6). The r2 and r2* increase as does the particle size [43, 46, 47].  
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 In SDR, whereτ D >1 Δwr , randomly distributed large agglomerations create an 
inhomogeneous magnetic field. If the particles or the size of the agglomerations are large enough, 
compared to the inter-particle distance, the diffusion of water is small and as such, it can be 
ignored. In this regime, r2 decreases with particles’ size and r2* reaches a constant value (figure 2-
6) [43, 47]. The r2 relaxivity tends to decrease in SDR regime due to the fact that the RF 
refocusing pulse becomes effective in rephasing the spins. Trend of the r2/ r2* relaxivity changes 
according to the regime where the particles are in. 
 
Figure 2-6: Sketch of the transverse relaxivity as a function of nanoparticle’s diameter in 
different dephasing regimes. This curve is a representative sketch of the curve shown in Ref. [27, 
43, 45]. 
 
Beyond the SDR, the induced magnetic field created by the magnetic particles is so strong that 
the adjacent protons are completely dephased. Accordingly, the surrounding water protons do not 
contribute to the MR signal [27]. Nanoparticle clusters and spherical-shaped particles 
demonstrate the same relaxivity behavior as their size varies. It was shown that nanoparticle 
cluster size was linearly related to the r2 of clusters in the MAR [44], and inversely related to the 
r2 of clusters in the SDR [48]. 
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2.2.2 Susceptibility contrast in MR images 
In this section, the susceptibility effect in MR images with a focus on the presence of magnetic 
particles in the region of interest is explained. According to the imaging sequence two types of 
artifacts (geometrical and intensity distortion) can occur in the images that are explained in 
details. 
2.2.2.1 Susceptibility 
A one to one relationship between a spin’s position and the frequency at which it precesses is 
the basis of the spatial encoding in the MRI. An inhomogeneity in B0 causes a variation in the 
precession frequency creating susceptibility artifacts in the MR images. Magnetic susceptibility is 
a dimensionless quantitative measure of the level of a material’s ability to induce a local 
magnetic field inhomogeneity within an applied homogeneous magnetic field. Macroscopic field 
inhomogeneities give rise to two types of artifacts: geometrical distortion and intensity distortion 
(echo shifting). The first artifact causes a misregistration of the spin’s location in the form of a 
shift in spins’ position or a "shearing" effect on the image, depending on whether the background 
gradient is parallel or perpendicular to the read-out direction. The second artifact only affects the 
gradient echo imaging. 
2.2.2.1.1 Geometrical distortion 
If a background gradient (G´x), parallel to the read-out gradient’s (Gx) direction, is present 
during the echo acquisition, the phase evolution of the spins alters [49]: 
( ) ( ) ''2' txGxGt xx +−= πγφ          (Eq. 2-6) 
( ) ''1'2' t
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x
x
x ⎟⎟
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⎜⎜
⎝
⎛
+−= πγφ          (Eq. 2-7) 
It is assumed that the read-out gradient is applied along the x-direction. As such, the spins 
residing at position x will be mapped to an apparent position x´ and the reconstructed spin density 
spatially differs from the physical spin density:  
⎟⎟
⎠
⎞
⎜⎜
⎝
⎛
+=
x
x
G
Gxx '1'          (Eq. 2-8) 
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The presence of the G´x causes the spins to be shifted parallel to the read-out direction. 
Increasing the applied read-out gradient is the only way to minimize the distortion. If G´x is 
known throughout the FOV, the distortion can be corrected through shimming.  
Any background gradient during data recording will change the frequency at which the spins 
precess and lead to a misregistration of the spins’ location. If G´ is perpendicular to the read-out 
direction (G´y or G´z), the spins will be shifted along the x-direction as a function of their position 
in the z or y-direction. If the background gradient is in the y-direction, the phase behavior during 
the read-out varies as following:  
( ) ( ) ''2' tyGxGt yx +−= πγφ          (Eq. 2-9) 
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y'' +=          (Eq. 2-11) 
This effect distorts the square shape of the voxel and as a result the reconstructed voxels 
contain information from the adjacent spatial locations.  
2.2.2.1.2 Intensity distortion 
 Due to the absence of the 180˚ refocusing pulse, intensity distortion pertains to the gradient 
echo sequences. In 2D Fourier transform (FT) the MR signal is given by [50, 51]: 
( ) ( ) ( )∫ ∫ ∫
∞
∞−
∞
∞−
∞
∞−
= dxdydzezyxMmns mnzyxi .,,,,,, φ          (Eq. 2-12) 
where n and m represent number of the time sample and that of the phase encoding step, 
respectively, and M represents the distribution of the magnetization right after the application of 
the RF excitation pulse.  
In the absence of a background gradient with slice selection along z, phase encoding along y 
and frequency encoding along the x direction, phase evolution during the sampling period is 
given by [50, 51]: 
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( ) yyx TGymtnxGzyx Δ+Δ= γγφ ,,          (Eq. 2-13) 
where Δt is the sampling interval, ΔGy is the step size of the phase encoding and Ty is the 
duration of the phase encoding gradient. 
The presence of field inhomogeneities perturbs the evolution of the phase in both SE and GRE 
sequences [50, 51]:  
( ) ( ) ( ) tnzyxBzyxzyxSE ΔΔ+= ,,,,,,' γφφ          (Eq. 2-14) 
( ) ( ) ( ) ( )zyxBTEtnzyxBzyxzyxGRE ,,,,,,,,' Δ+ΔΔ+= γγφφ          (Eq. 2-15) 
Here, φʹ′ and φ  indicate the perturbed and the unperturbed phase evolutions, respectively, and 
ΔB(x,y,z) indicates the induced inhomogeneity in B0. The first added term ( ( ) tnzyxB ΔΔ ,,γ ) 
causes a geometrical distortion in both the SE and GRE sequences. The term ( )zyxBTE ,,Δγ  
occurs in GRE sequences only and it leads to a temporal shift in the echo during the signal 
acquisition period. Figure 2-7, illustrates how a background gradient shifts the echo to left or 
right within the sampling window. Peak of the gradient echo arises when the area under the two 
opposing read-out lobes is equal. A negative or a positive gradient during the application of the 
read-out gradients causes the gradient echo to take place later or earlier in time. As such, a loss of 
signal occurs in the voxels where the background gradient is present. 
Background gradients in the slice-selection direction cause a shift in the origin of the k-space 
and therefore, the signal can be reduced significantly [52]. Although this effect can occur in both 
the SE and GRE images, the magnitude of the shift is greater in the GRE.  
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Figure 2-7: Effects of negative and positive background gradients during data acquisition on 
echo shifting in GRE-based sequences. 
 
2.2.2.2 Magnetic particles in external fields 
Ferromagnetic materials have a rather high susceptibility. A magnetic sphere of radius a and 
constant susceptibility surrounded by uniform space and subjected to a uniform magnetic field, 
such as B0 creates a magnetic field corresponding to the field of a magnetic dipole given by [68]: 
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         (Eq. 2-16) 
where µo=4π×10-7 is the permeability of the free space, rˆ  is the r-directional unit vector, zˆ  is 
the unit vector in z-direction, B0 is the external uniform magnetic field and m
!  is the magnetic 
dipole moment calculated by: 
zMam sat ˆ3
4 3 !! π=          (Eq. 2-17) 
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where satM
!
and a correspond to the saturation magnetization and the radius of the sphere, 
respectively (figure 2-8). 
 
Figure 2-8: Presentation of magnetic field at position r! outside of a magnetic sphere with 
radius a. 
In the continuous boundary condition across the spherical sphere, change in the z-component 
of the magnetic field is (figure 2-9): 
( )
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         (Eq. 2-18) 
The magnetic field introduces an inhomogeneity in the homogenous magnetic field of MRI. The 
inhomogeneity affects the MR signal by adding an additional phase term [49, 53]: 
zBTEΔ=Δ γφ          (Eq. 2-19) 
The phase term varies linearly with TE and is proportional to the induced magnetic field.  
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Figure 2-9: Simulated magnetic field lines (in Tesla) (left) and the dephased volume caused by 
a magnetic particle (see Equations. 2-18 and 2-19) (right). 
 
As described in section 2.2.2.1.2, a magnetic gradient introduces an intensity distortion in the 
GRE images in the form of a signal loss. The time-dependent modification to the MR signal (S) 
caused by a magnetic particle is hence proportional to an integral over the precessing proton 
density within the volume of interest:  
( )∫ Δ−= dzezyxs i ϕρ ,,          (Eq. 2-20) 
The above equation can be used to simulate the signal loss artifact in the GRE images. It also 
allows studying the effects of TE and properties of the magnetic particle on the extent of the 
signal loss. However, the equation addresses the signal loss due to echo shifting effect only. 
Several studies have been conducted on the simulation of signal loss artifact in different MR 
sequences [50, 51, 54-59]. In [60], GRE imaging of individual magnetic particles was 
numerically simulated. A theoretical single-voxel was simulated a) based on both the geometrical 
distortion and the echo shifting and b) based on the echo shifting only (figure 2-10). The results 
showed a significant difference in the form and the extent of the simulated signals in the high 
resolution images (<100 µm). However, for image resolutions of more than 200 µm, no 
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significant deviation was observed in the simulated signals. The results implied that the intensity 
distortion is the dominant effect over the geometrical distortion in the susceptibility-based 
artifacts in GRE sequences.  
 
Figure 2-10: Reproduced from [60]. Comparison of voxel signals with and without geometrical 
distortion correction. Solid curves are numerical simulations including geometrical and intensity 
distortions. Dashed curves include only intensity distortion. Curve labels show image resolution 
in micrometers. 
2.2.3 Real-time MR imaging techniques 
Real-time resonance imaging refers to the continuous tracking of a moving organ or object within 
the FOV. It finds application in cardiovascular imaging, functional studies of joint kinetics, 
noninvasive monitoring of intervention procedures or contrast agents. In this section, GRE-based 
fast MR techniques are discussed.  
2.2.3.1 Echo planar imaging 
Echo planar imaging (EPI) is one of the fastest imaging sequences which find an application in 
dynamic studies and real time imaging such as diffusion imaging, perfusion imaging, cardiac 
imaging and neurofunctional brain mapping. In EPI a train of gradient echoes is produced in each 
TR. Each echo fills one k-space line. In a single-shot EPI all the k-space lines are filled during 
one TR. Following the excitation pulse and before the transverse magnetization decays away 
completely, a bipolar oscillating read-out gradient is applied to generate an echo train. Each 
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gradient echo is then phase-encoded individually so that multiple k–space lines can be filled in a 
single excitation.  
 
Figure 2-11: Gradient echo EPI acquisition. 
The reversal of the readout gradient reverses the k-space trajectory for every other gradient 
echo. This effect should be corrected prior to reconstruction of the image. In gradient EPI, each 
k-space line is filled with a gradient echo acquired at a different TE the amplitude of which 
decays according to: 
S n( ) = S0e−TE n( )/T2
*
         (Eq. 2-21) 
The TE corresponding to the central k-space line is known as the effective TE (TEeff) and 
determines the image contrast. Position of the k-space central line can be controlled by the phase-
encoding gradients. Single-shot EPI has an excellent temporal resolution (~ 100 ms) at the cost of 
low signal to noise ratio (SNR), a low spatial resolution and distinct artifacts.  
Reduction of the acquisition time in EPI sequences has been carried out by decreasing the echo 
train time through either reducing the number of echoes or applying a faster gradient. These 
techniques are known as parallel imaging, partial Fourier, sparse sampling and gradient ramp 
sampling.  
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The speed of data acquisition depends on the speed of gradient encoding, which is controlled 
mainly by the switching rate of the gradient fields. Despite recent improvements in performance 
of the encoding gradients to satisfy the need for fast imaging, the switching rate is limited by 
neural stimulation in the patients. In order to solve this problem, alternative encoding methods 
such as parallel imaging have been proposed.  
Parallel imaging is a technique developed for faster imaging, based on phased array coils. 
Multiple surface coils each having an intrinsic spatial sensitivity are used in this technique. The 
influence of the coil sensitivity is regarded as an encoding effect analogous to gradient encoding. 
The number of phase encoding steps is reduced by increasing the readout lines spacing. 
Reduction in the phase encoding steps results in a reduction in the field of view (FOV) and 
consequently the so-called aliasing (wrapping) effect. In the presence of one receiver coil the 
aliasing effect is irreversible. However, applying the multiple-coil acquisition approach allows 
for reconstruction of the FOV without the aliasing artifact. There are two main methods to 
remove aliasing in parallel imaging; sensitivity encoding (SENSE) [61] and simultaneous 
acquisition of spatial harmonics (SMASH) [62].  
Depending on local coil sensitivities, aliasing occurs with different weighting in each 
individual image. In SENSE, to reconstruct an unfolded image, the images obtained from all coils 
are combined using coil sensitivity maps. The acquisition time is reduced by a factor known as 
the reduction factor that is determined by the number of k-space lines being reduced. Due to the 
coil sensitivities, the spatial weighting of the MR signal is analogous to the spatial weighting 
provided by the sinusoidal Fourier encoding functions. In SMASH, the linear combination of the 
coil sensitivities approximates the sinusoidal functions corresponding to the missing k-space 
phase-encoding lines.  
EPI suffers from two major sources of artifacts; Nyquist ghosts and geometric distortions. As 
mentioned earlier, direction of the k-space lines for odd echoes is opposite to that of the even 
echoes, requiring correction prior to the Fourier reconstruction. To this end, the k-space data are 
time-reversed along the readout direction for the alternative k-space lines. This reversal results in 
an inconsistent phase accumulation in odd and even k-space lines ( ( )( )ϕin1exp − ), which in the 
spatial domain causes a displacement of signal intensity halfway across the image in the phase 
encoding direction. A common way to correct this displacement is to acquire an EPI image, 
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called calibration scan, while the phase encoding gradients are off. One dimensional Fourier 
transform of the ky line determines the offset of the echo center for each ky line [63, 64]. 
However, if a local B0 inhomogeneity varies along the phase-encoding axis, the correction 
method becomes inadequate.  
Presence of background inhomogeneity leads to misregistration of the spins in the images 
known as geometrical distortion. The degree to which spin positions are distorted is directly 
proportional to the intensity of the field inhomogeneity and inversely proportional to the 
magnitude of the encoding gradient. Due to the use of a series of blips with a very low bandwidth 
and magnitude in the phase encoding direction (figure 2-11), a considerable image distortion is 
observed in this direction in the EPI images. In addition, the presence of a field inhomogeneity, 
such as a magnetic particle, severely deteriorates the geometrical distortion.  
Despite the excellent temporal resolution of the EPI scans which makes real-time and dynamic 
imaging feasible in many applications, the sequence is not efficient when there is a strong source 
of magnetic susceptibility in the FOV such as a magnetic particle.  
2.2.3.2 Steady state imaging 
Steady state is a condition in the GRE sequences achieved through the application of repetition 
times shorter than T1 and T2 of the tissue. As such, the value of the longitudinal magnetization at 
the corresponding points in adjacent TR intervals is equal. Since the TR is very short, there is not 
enough time for T1 and T2 to naturally decay. Therefore, both the longitudinal and the transversal 
magnetizations coexist. The transversal magnetization remaining at the end of each TR is called 
the residual transverse magnetization (RTM). Steady state sequences can be classified into two 
main categories based on the state of the RTM; whether it reaches zero (spoiled) or a non-zero 
steady value (steady state free precession) before the application of the next excitation pulse.  
In order to remove the RTM, spoiler gradients may be applied at the end of the pulse sequence. 
Spoiler gradients dephase the transverse magnetization along the direction they are applied 
whereas the longitudinal magnetization experiences no effect. RF spoiling is another technique 
used to spoil the RTM. During this process a phase variant (Φ j ) excitation pulse is applied at 
each TR. The phases can vary randomly or according to a phase-cycling schedule such as 
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Φ j =Φ j−1 + jΦ0 [65]. Therefore, the RTM has random phase at each TR and the phases do not 
accumulate to build up a residual magnetization.  
According to the Bloch equations, the longitudinal magnetization at the end of the jth TR is: 
( )11 /0/1 1 TTRTTRjj eMecosMzMz −−− −+= θ          (Eq. 2-22) 
Once the steady state condition is reached where; 
Mzj =Mzj−1 =Mz          (Eq. 2-23) 
The steady state longitudinal magnetization becomes equal to: 
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Rephasing of the FID at an echo time TE (
*
2/TTE
z eSinM
−θ ) produces a signal in a spoiled GRE 
acquisition: 
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Sspoil defines how the longitudinal magnetization responds to the first RF excitation pulse. If 
the longitudinal magnetization experiences j excitations (j ≥	 1) the steady state expression for the 
spoiled GRE is: 
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MRI sequences that are based on the steady-state free precession extract the FID either 
immediately after the RF; the echo signal preceding the next RF pulse or a coherent sum of both 
signals. Therefore, SSFP signal can be categorized to SSFP-FID and SSFP-echo (figure 2-12). To 
avoid spoiling the RTM, excitation pulses should have the same phase in the rotating frame and 
the transverse magnetization should also accumulate equal phases at each TR interval. The latter 
condition is attained when the gradient areas are identical at all TR intervals.  
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Figure 2-12: Steady-state gradient echo (SSFP-FID) sequence 
 
If during each TR the total gradient area on all three axes is zero another form of steady state is 
reached where both the FID and the Echo signals superpose (balanced SSFP or True-FISP). The 
balanced gradients refocus both signals at the center of the TR interval as a single echo (figure 2-
13).  
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Figure 2-13: Balanced SSFP sequence. 
The signal intensity for the balanced sequence is given by [66]: 
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         (Eq. 2-27) 
Where M0 is the magnetization at equilibrium and α is the flip angle. In steady state, TR is 
nearly always much shorter than T1 or T2, consequently the equation reduces to: 
( )( )
2/
21
0 cos1cos1
sin TTEe
TT
MS −
−++
=
αα
α          (Eq. 2-28) 
When a signal is recorded at TE ≈ TR/2, in the final term T2*will be replaced by T2. In [67], it 
was shown that a complete refocusing occurs at TE = TR/2. Therefore, once TE is set at TR/2, 
the steady state signal is weighted by 2/TTEe−  whereas other GRE sequences are weighted by 
*2/TTEe− . According to Eq. 2-28, balanced SSFP has a T2/T1 contrast weighing. Tissues with equal 
T1 and T2 relaxation times (fluids and fat) produce a hyperintense signal and appear bright in the 
images. Table 2-1 shows the commercial names of steady state pulse sequences used by MR 
scanner vendors. 
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Table 2-1: Commercial names of steady state pulse sequences used by MR scanner vendors 
Vendor Spoiled GRE SSFP-FID SSFP-Echo Balanced SSFF 
Siemens FLASH FISP PSIF True FISP 
General Electric SPGR GRASS SSFP FIESTA 
Philips T1-FFE FFE T2-FFE Balanced FFE 
 
2.3 Vascular imaging 
Several techniques have been developed to visualize vascular networks. These techniques 
differ in accuracy, penetration depth, acquisition time, computational effort and provided 
information. A variety of visualization techniques including contrast-enhanced computerized 
tomography (CT) or MRI and post-processing analysis such as volume and surface rendering has 
been developed to display vascular structures and their surroundings more clearly. In this section, 
different angiography techniques and their ability in resolving microvasculatures are discussed. 
2.3.1 Imaging modalities in angiography 
The need to understand the vascular anatomy of a tissue has led to development of different 
imaging techniques helping to visualize small blood vessels in a 3D fashion. Digital subtraction 
angiography (DSA) is considered the reference imaging modality in the visualization of the 
vascular network, evaluation of intracranial aneurysm and analysis of the stenosis in arteries [68-
71]. DSA provides a resolution of ~180 µm. However, the approach involves invasive intra-
arterial insertion of a catheter and an iodinated contrast agent that is potentially nephrotoxic. On 
the other hand, the contrast level of the intravenously injected iodine drops rapidly, leaving not 
enough time for vasculature imaging [72]. Due to the invasive catheterization procedure involved 
in this procedure and the resultant 2D images, the application of DSA has been replaced by other 
noninvasive or less invasive 3D techniques such as Doppler ultrasonography, magnetic resonance 
angiography (MRA) and computed tomography angiography (CTA) [73, 74].  
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Color Doppler ultrasonography has a spatial resolution of 200 µm with a relatively poor 
penetration depth making the imaging limited to the superficial parts of the body. Acoustic 
angiography is a new technique that provides high resolution images of the superficial 
microvasculature [75, 76]. Low penetration depth, in the order of a few millimeters, is the main 
limitation of this technique. 
CTA is an angiography technique that uses a narrow x-ray beam along with multiple detector 
arrays rotating around the region of interest to produce cross-sectional data. The cross-sectional 
data is then analyzed through reconstruction algorithms to generate angiograms. CTA can 
provide excellent details of the vascular tree in small arteries. A limitation of 3D-CTA is the 
inability to resolve blood vessels with a diameter less than 400 µm [77]. CTA also delivers a high 
dose of radiation which limits the number of examinations a patient can undergo due to the 
carcinogenic potential of x-ray exposure [78]. 
A lengthy imaging time has been considered a major drawback of the MRA compared to the 
CTA. However, the recent development of 32-channel coils and introduction of parallel imaging 
acceleration techniques have significantly reduced the imaging time [79]. Contrast-enhanced 
MRA methods require an injection of paramagnetic gadolinium-based Chelate agents through a 
peripheral vein. Blood relaxation times are shortened by the effect of paramagnetic agents. This 
effect causes blood to appear bright on T1-weighted images. Pre- and post-injection images are 
then subtracted to remove the surrounding tissues, generating an image of the vascular network 
within the region of interest. Using this technique, vessels with a size of 300 µm in diameter can 
be detected in MR images of a clinical scanner [80].  
Time of flight (TOF) and phase contrast (PC) are two techniques in MRA to depict the 
vasculature without administration of an intravenous contrast. In TOF, inflow of fully magnetized 
spins to the imaging volume results in an increase in the received signal while the outflow of the 
spins results in decreased signal intensity. In the PC, blood moving spins in the same direction as 
the magnetic field gradient accumulates a phase shift proportional to their velocity while 
stationary spins gain no phase shift after application of the gradients. This information is used to 
determine the velocity of the blood flow. Subtraction of the image obtained with the velocity 
encoding gradient from that without the velocity encoding gradient yields an angiogram. A 
greater signal to noise ratio can be achieved using high field MR scanners (3.0 T and 7.0 T). In 
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[81], it has been demonstrated that the above mentioned non-contrast enhanced MRA techniques 
can be used to visualize the first- and second-order intracerebral arteries branches with a spatial 
resolution of 0.57 mm and 0.43 mm at 3.0 T and 7.0 T, respectively. On the other hand, high field 
7.0 T MR scanners have a very limited availability for clinical applications due to a high cost. 
Both techniques (TOF and PC) rely on the blood movement. Such motion dependence limits their 
application in areas of low or turbulent flow.  
Vascular ultrasound is a non invasive method used to examine the blood circulation through 
reflection of transmitted high frequency sound waves. Micron-sized gas bubbles scatter sound 
waves significantly. They have been used as intravascular contrast agents in vascular 
ultrasonography. Tube phantoms with an internal diameter of 255 µm can be visualized through 
estimation of the individual micro bubbles [82, 83]. However, the technique is limited in 
penetration depth restraining their application in visualization of the superficial vasculature or the 
vascular network in small animals.  
Optical coherence tomography (OCT) angiography is a non invasive method widely used in 
3D visualization of retinal and choroid vasculature that has achieved micrometer-level axial 
resolution [84, 85]. However, the scanning depth and the field of view are both limited to a few 
millimeters [86]. Table 2-2 compares different imaging modalities in terms of the spatial and 
temporal resolution and the imaging depth. 
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Table 2-2: Summary of differences between imaging modalities 
 Spatial 
resolution 
Time scale Imaging 
depth 
Primary contrast 
X-ray / CT ~ 0.2 mm millisec to 
sec 
No limit x-ray absorption by 
tissues 
 SPECT * ~ 4 mm min No limit radiolabel atoms decay 
in tissues 
PET ** ~ 2 mm min No limit radiolabel atoms decay 
in tissues 
MRI ~ 0.5 mm sec No limit tissues proton density 
Ultrasound ~ 50 µm millisec mm - cm tissues impedance 
difference 
OCT ~ 10 µm sec to min ~ 1-3 mm tissue’s characteristic 
in scattering light 
*  Single-photon emission computed tomography 
** Positron emission tomography 
2.3.2 Visualization of microstructures 
Different techniques including microscopes, pre-clinical and clinical imaging modalities have 
attempted to visualize the microstructures in-vivo and in-vitro. In section 2.3.2.1 the techniques 
applied to visualize microvasculatures and their clinical limitations are reviewed. In the following 
section (2.3.2.2) the application of MR scanners in molecular and cellular imaging is presented.  
2.3.2.1 Microangiography 
Vascular imaging has several applications including creation of a map for the vascular 
architecture, measuring blood flow and vascular permeability and monitoring variations in the 
vessels’ wall. Visualization of the blood vessels in tumors allows for evaluation of the efficiency 
of applied treatments such as chemotherapy, radiation therapy and targeted therapy. Microscopic 
methods are useful tools for displaying the structural and functional changes in the vasculature 
supplying the tumors. They provide the highest image quality and spatial resolution. Confocal 
microscopy and multiphoton microscopy have a resolution of ~100 nm and electron microscopy 
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provides an unsurpassed resolution of a few nanometers [87]. Most microscopy techniques rely 
on histological tissue sections. Optical frequency domain imaging (OFDI) is a microscopy 
imaging technique with the ability to depict microvasculature in vivo. Tumor angiogenesis in a 
mouse brain is imaged using OFDI at a resolution of 10 µm [88, 89]. 
Advanced clinical and preclinical imaging methods are available to localize angiogenesis sites 
and acquire functional data in animals and in the human. Magnetic resonance imaging, computed 
tomography, positron emission tomography, ultrasonography and optical imaging are 
noninvasive methods that provide functional and structural information on the angiogenesis. 
Current clinical angiography methods such as DSA are excellent tools for visualization of the 
larger arteries and veins but not the microvasculature in tumors. High field 7 T MR scanner has 
shown to have superior resolution to conventional angiography images including 1.5T and 3 T 
MRA, and even comparable to DSA (figure 2-14) [90]. However, the clinical application of such 
scanners remains to be approved.  
 
 
Figure 2-14: Reproduced from [90]. Angiography images acquire from a 7 T MR scanner (a), 
which was superior to 1.5 T images (b) and comparable to DSA (c). 
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Preclinical techniques such as microMRI and microCT provide a spatial resolution of ~20 µm 
in angiogenesis imaging in ex-vivo experiments and small animal models (figure 2-15) [91-93]. 
Long scanning time in the microCT involves large radiation exposures which can exceed the 
lethal dose limit in the animals.  
 
Figure 2-15: Reproduced from [93]. Contrast-enhanced microMRI images of the vasculature 
development acquired from a mouse embryo using a 7 T preclinical scanner.  
 
Surface coils allow for high resolution imaging in the MRI. They consist of a single or double 
loop copper wire that is placed near the desired imaging area. However, due to the rapid signal 
uniformity decline while moving away from the center of the coil, their penetration depth is 
limited. Therefore, they have the highest SNR but a limited sensitive area. 
Microvascular density is an indirect method for angiogenesis quantification providing number 
of the blood vessels per unit area of a section. In [94], an array of surface coils measuring 2 cm2 
in area was used to acquire high resolution fMRI images (0.55 mm) of human brain at 7 T 
originated from the neuronal-specific microvasculature. The penetration depth of the surface coils 
was limited to 3.5cm. Using dynamic contrast-enhanced echo-planar imaging, Gadolinium based 
contrast agents have also been used to estimate the microvessel intensity in the human brain [95]. 
The skin microvasculature can be imaged using the surface coils in the clinical MR scanners 
[96, 97]. Human calf skin microvasculature was imaged at 1.5 T using a high temperature 
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superconducting  surface coil with a mean diameter of 13 mm. The surface coils offer sufficient 
sensitivity to depict human calf vasculature at a resolution of 80 µm3.  
MR contrast is closely correlated with the tumor’s microvessel intensity. The amount of 
contrast generated by a contrast agent is proportional to its magnetization saturation. Highly 
magnetic particles may be used to visualize tiny vasculatures in the MR images. Newly 
developed Fe-Cographitic carbon shell nanocrystals (FeCo/GC) showed to have the highest 
magnetization among all the magnetic materials allowing to obtain a very high sensitivity [98]. It 
was shown that microvessels as small as 100 µm can be resolved in the superficial circumflex 
iliac artery and branches of a rabbit model at 1.5 T MR using a custom designed surface coil (2.3 
cm in diameter) (figure 2-16). 
 
Figure 2-16: Reproduced from [98]. In vivo high-­‐resolution MRI: (a) a vasculature MIP image 
enhanced by 1-­‐mM blood pool concentration of ferumoxtran-­‐10, (b) a vasculature MIP image 
enhanced by 0.2-­‐mM blood pool concentration of FeCo/GC, (c) picture of 2.3 cm diameter 
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custom designed surface coil and (d) Cross-­‐sectional signal intensity plot across a small 
vasculature. 
2.3.2.2 Cellular and molecular imaging 
Cellular scale resolution can be achieved by using clinical and preclinical MR scanners. 
Magnetized cells create a localized magnetic inhomogeneity in the MRI’s uniform magnetic field 
and appear as a signal void artifact in the images. Susceptibility weighted imaging (T2* weighted 
gradient echo) provides a mean to detect the cells through the generated artifact [99]. Cellular 
scale resolution can be achieved by using clinical and preclinical MR scanners. Magnetized cells 
create a localized magnetic inhomogeneity in the MRI’s uniform magnetic field and appear as a 
signal void artifact in the images. Susceptibility weighted imaging (T2*- weighted GRE) provides 
a mean to detect the cells through the generated artifact [100]. Vessels appear as hypersignal lines 
in the SE images and as hyposignals in the GRE images. However, hyposignals related to the 
labeled cells are not detectable in the SE images. Therefore, the difference of the two scans can 
reveal the hyposignal areas related to the presence of iron oxide nanoparticles. As opposed to the 
vasculature, signal voids have a focal nature that can be confirmed in 3D images. Hence, the 
exact correspondence of the signal void in the three imaging planes confirms that the hypointense 
signal is due to the labeled cell and not a microvessel [101].  
As mentioned above, T2*-weighted GRE images are highly sensitive to all types of 
inhomogeneities. As such, they have a poor specificity to the SPIOs. T1 and T2-weighted spin 
echoes are less sensitive to the presence of the SPIOs than the T2* measurements. However, due 
to the refocusing of the background field inhomogeneities, they have a higher specificity to the 
presence of the SPIOs. Balanced steady state free precession (b-SSFP) is a gradient echo 
sequence where a coexistence of both longitudinal and transversal magnetizations is present. This 
condition is met when the TR is shorter than the T1 and T2 times of the tissue. As such, the 
images are weighted on the T2/T1 ratio. This sequence (known as FIESTA and True- FISP in GE 
and Siemens scanners, respectively) provides a high sensitivity to the presence of SPIOs [102, 
103]. It has been shown that the True-FISP has the highest sensitivity among all the imaging 
sequences including GRE, EPI and SE for single cell detection in MRI [103].  
Compared to the magnitude images, phase images are particularly sensitive to small deviations 
of the resonant frequency. However, these images are contaminated by the static field 
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inhomogeneities as well as the phase wrapping. The static field inhomogeneity has a low 
frequency content that can be eliminated by the use of a high pass filter [104, 105]. Most of the 
studies on the in-vivo detection of the labeled cells using the MRI employ pre-clinical scanners 
with a high magnetic field strength (figure 2-17) [99, 100, 106-110]. In some studies, clinical 1.5 
T scanners were used to detect individual labeled cells in a mice model [101, 111]. In these 
studies, high temperature superconducting coils or custom made gradient coils with a strength of 
several hundreds of millitesla per meter were employed to improve the spatial resolution  
Visualization of the single cells in MR images using SPIO nanoparticles depends on the iron 
load in each of the labeled cells. Nanoparticles are generally internalized through a phagocytosis 
pathway. The particles primarily absorb on the membrane and subsequently form the 
nanoparticle-loaded vesicles. The vesicles then fuse with the endosomes within the cell’s cytosol. 
During the division process the daughter cells share the magnetic endosomes in which case the 
iron load is halved. To overcome this problem, application of micron-sized iron oxide particles 
(MPIOs) is proposed [60]. Since each cell is labeled with a single magnetic particle, the daughter 
cell will always carry the label. MPIOs are endocytosed by a variety of cells making them an 
appropriate candidate for cell labeling [112].  
 
Figure 2-17: Reproduced from [109]. Detection of single cells using a 9.4 T MR scanner at an 
in-plane resolution of 23.5 µm. Slices of agarose gel containing 105 (a) and 103 (b) labeled cells. 
2.4 Summary of the literature review 
Magnetic resonance navigation was introduced as a new technique for controlled delivery of 
therapeutic agents to the cancer cells through application of magnetic gradients. One important 
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step in this intervention is providing, in advance, a 3D map of the local vasculature leading to the 
tumor site.  
Subsequently, the theory of MRI, and the application of superparamagnetic agents in the MRI 
were investigated in enhancing the image contrast. Superparamagnetic iron oxide particles were 
found to have a great potential in vascular imaging through application of the susceptibility 
effect. Susceptibility-based artifact is a way to amplify the effect of a magnetic particle, whereas 
its dimension is largely smaller than the spatial resolution of the system. Micron-sized magnetic 
particles act as imaging probes in the cellular and molecular imaging using preclinical MR 
scanner in the animal studies. Different types of artifacts and misregistrations in the MR images, 
caused by the presence of the magnetic materials, were studied to better understand how these 
particles alter the MR signal and to identify the potentials to control the extent of the magnetic 
particles’ effect on the MR images.  
Real-time MR imaging sequences and effects of magnetic particles’ presence were 
investigated. It was found that, owing to their high specificity for detection of magnetite particles, 
the fast steady-state True-FISP MR sequences have a great potential for real-time tracking of the 
magnetic particles. 
Finally, the current clinical imaging modalities and their capability in resolving the 
microvascular networks were studied. Poor spatial resolution and/or low penetration depth of the 
current clinical imaging modalities is the main limitation in resolving the microstructures 
including the capillaries and the arterioles.  
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CHAPTER 3  OBJECTIVES, HYPOTHESES AND GENERAL 
METHODOLOGY 
Visualization of microstructures is beyond the capabilities of the current clinical imaging 
modalities, whereas it can be applied to many research areas such as the real-time drug delivery 
to tumor sites using an MRI system. MRI contrast agents (superparamagnetic) have been used in 
preclinical imaging modalities to visualize a single cell in small animals. We propose benefiting 
from the higher visibility of micron-sized magnetic particles in the microvessel blood streams to 
identify the vascular routes using clinical scanners. 
Therefore, the research question can be defined as: 
Does the application of micron-sized agglomerations of Iron Oxide nanoparticles in the MRI 
allow for identification of micrometric vascular routes, not detectable using current clinical 
imaging modalities? 
In MRI, the susceptibility-based contrast provides a way to amplify the effects of a magnetic 
microparticle, whereas its volume is largely inferior to the spatial resolution of the system. This 
concept initiates an approach for visualization of microstructures such as microvessels by means 
of the susceptibility artifact. In the MRN, therapeutic microcarriers or contrast agents are injected 
through an infusion catheter which is advanced under a fluoroscopic guidance into an appropriate 
artery. However, the extremity of the catheter can only be advanced to the arterial level while the 
tumor is located at the capillary level. Therefore, upon release of the therapeutic microcarriers, 
magnetic gradients are applied to steer the magnetic microcarriers to the tumor site. Magnetic 
gradients are applied according to a predefined map of the local vasculature leading to the tumor 
site. Preparation of such a map is an essential step in the MRN intervention. 
3.1 Objectives and hypotheses 
The general objective of this study was to prepare a 3D map of the microvascular route starting 
from where the catheter tip is placed to the tumor site before the MRN intervention. More 
particularly, the envisaged steps in the identification of the vascular routes were:  
i) Releasing “scout microparticles” in an unknown vascular network leading to the tumor site,  
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ii) Tracking the “scout microparticles” through a real-time MR imaging,  
iii) Positioning the “scout microparticles” through their susceptibility effect on the images,  
iv) Assembling the calculated positions to identify the local vascular network. 
The general objective of this project was fulfilled through four specific objectives. 
Objectives 1 and 2 permit to evaluate the following research hypothesis: 
Susceptibility artifact caused by the presence of a magnetic microparticle in the 
homogeneous magnetic field of a clinical MR scanner can reveal the presence and the 
position of the particle with a sub-pixel accuracy.  
Objective 1: 
• Study the behavior of the susceptibility artifact created by the magnetic microparticles 
considering different MRI sequences and magnetic particles; 
• Study the visibility limit of such particles in the clinical MR scanners through simulation and 
phantom studies.  
Objective 2: 
• Study the behavior of micron-sized agglomerations of iron oxide nanoparticles in the MR-
images to replicate the susceptibility effect of the magnetic microparticle. 
 
Objectives 3 and 4 permit to evaluate the following research hypothesis: 
 A micron-sized agglomeration of iron oxide nanoparticles can serve as a biocompatible, 
biodegradable contrast agent in the visualization of microstructures using a clinical MR 
scanner and a susceptibility-sensitive sequence. Real-time tracking of such microparticles 
leads to reconstruction of the microvasculature.  
Objective 3: 
• Propose an algorithm for 3D reconstruction of the vascular network through which magnetic 
particles travel; 
• Study the validation of the proposed technique through a simulation study. 
Objective 4: 
• Validate the proposed algorithm in 2D and 3D synthetic models in a micrometric scale.  
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3.2 General Methodology 
In order to attain objectives 1 and 2, simulation studies and phantom experiments were 
performed to find out sensitivity of a clinical MR scanner in detecting magnetic microparticles. 
Knowing about the accuracy of magnetic particles’ positioning through their susceptibility effect 
in the MR images was also an area of interest. Highly magnetic stainless steel beads of different 
diameters were used to evaluate the detection limit of the clinical MR systems using 1.5 T and 3T 
scanners and commercial head coils. The susceptibility signals were simulated according to the 
bead’s dimension and their magnetic properties. The results showed that using a clinical MRI 
system, a single 15 µm microsphere is detectable in the GRE scans. The amount of the 
susceptibility artifact was found to be related to the scan parameters and the particles' size. The 
simulation results were subsequently compared to the MRI signal to estimate the accuracy of the 
simulation. The effect of imaging parameters was verified on the extent of the susceptibility 
artifact (Appendix A). 
Shape and amount of the susceptibility artifact for various spacing and angulations between the 
microparticles were studied afterwards using simulations and phantom experiments. In an FOV, 
the particles are distributed in an unknown fashion. Since the susceptibility effect is much larger 
than the actual particle’s size, if the spacing between the particles is smaller than a certain limit, 
the artifacts generated by the individual particles are almost entirely superimposed. We showed 
that for a pair of identical particles saturated in the MRI’s magnetic field with a diameter of D, 
the signal loss starts to change when particles are separated ~15×D and they become fully 
distinguishable when their distance reaches ~ 40×D (Appendix B). This study helps to 
characterize the MR signal in the presence of several particles in the FOV. The obtained cutoff 
values (15×D and 40×D) are essential in the injection of microparticles as susceptibility effects 
from the individual particles may otherwise superimpose.  
As it was discussed in the literature review, compared to the nanofabricated contrast agents, 
micrometer-sized agents can benefit from higher magnetic moments. Our first study 
demonstrated that, a single 15 µm diameter ferromagnetic microsphere with a high susceptibility 
is just visible in the T2*-weighted GRE images. However, ferromagnetic materials tend to 
maintain a high remanent magnetization, limiting their application in the MRI environment. On 
the other hand, superparamagnetic particles have unique properties, making them interesting 
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candidates to be used as the MRI contrast agents discussed in Section 2.2.1.2. As the next step, 
the effects of microagglomerations composed of Fe3O4 nanoparticles were studied in the MR 
images. These agglomerations can resemble the signal loss behavior of microparticles in an 
image. In our first article (Chapter 4), we generated agglomerations of the Fe3O4 and studied their 
visibility in microchannels with internal diameters of 200 and 50 µm. These diameters fairly 
approximate sizes of a narrow artery or a large arteriole and a small arteriole, respectively. The 
size controlled micro-drops consisting of an oil-based microfluid of Fe3O4 were generated by 1) a 
T-junction microfluidic device and 2) suspension of oil in water in the presence of a surfactant. It 
was confirmed that the microagglomerations of nanoparticles are a promising candidate for 
reproduction of microparticles’ effect in the MR images. It was also confirmed that the method is 
reproducible and accurate at the sub-pixel level.  
In order to achieve our objectives 3 and 4, a synthetic microvascular network was dynamically 
mapped through the injection of Fe3O4 agglomerations and was scanned in real-time (Chapter 5). 
The vascular network was designed to have an inlet channel branching into eight smaller 
channels in a three-stage division with an inner diameter of 150 µm. The imaging was performed 
using a 1.5T MR scanner, a typical 8-channel head coil and over a relatively large FOV (16×16 
cm2). Particles were localized through "Center Of Gravity" (COG) of the artifacts which they 
generated in the images. The results of this study suggested the accuracy of the 2D reconstruction 
of the microvessels characterized by a measured average error of approximately half of a pixel’s 
size. Limits of a 1.5 T scanner in detecting such microagglomerations were also investigated. We 
showed that the agglomerations measuring 50 µm in diameter are detectable in the MR images. 
In this study, we developed a reliable technique for generation of uniform magnetic boluses 
(microagglomerations of iron oxide nanoparticles) through a T-junction microfluidic device made 
of Plexiglas and treated with Silica to obtain a hydrophilic surface. With the applying of this 
technique, we were able to control size of the agglomerations as well as their spacing.  
In the third article (Chapter 6), we proposed a method for 3D mapping of vascular networks 
through a fast multi-slice multi-acquisition MR sequence. A simulation study was performed to 
validate the feasibility of the proposed algorithm. A phantom study was then performed in a glass 
made artificial network using microagglomeration of Fe3O4 nanoparticles. The agglomerations 
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were positioned in a 3D space and all the extracted x, y and z coordinates were assembled to build 
up a 3D distribution of the artificial vascular network.  
For the phantom studies, micro channels were fabricated on Plexiglas. We also developed a 
technique to form agglomerations of oil-based ferrofluid in water through a T-junction geometry. 
In chapter 7, the fabrication process and the technique to generate oil in water droplets are 
explained and illustrated.  
Our results confirmed the possibility of tracking trajectory path of the iron oxide microparticles 
injected in a vascular network using a susceptility-sensitive fast MRI sequence. An assembly of 
the trajectory maps can represent the local vasculature which is smaller than the spatial resolution 
of the MR scanner 
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CHAPTER 4 ARTICLE 1: MAGNETIC RESONANCE IMAGING OF 
MICROVESSELS USING IRON-OXIDE NANOPARTICLES 
N. Olamaei1,2, F. Cheriet2 and S. Martel1 
1 Nanorobotics laboratory, École Polytechnique Montréal, Montreal, Canada 
2 Imaging and 4D Visualization laboratory, École Polytechnique Montréal, Montreal, Canada 
4.1 Abstract 
The visualization of microstructures including blood vessels with an inner overall cross-
sectional area below approximately 200 µm, remains beyond the capabilities of current clinical 
imaging modalities. But with magnetic resonance imaging (MRI), magnetic entities cause 
susceptibility artifacts in the images by disrupting the homogeneous magnetic field in a much 
larger scale than their actual size. As validated in this paper through simulation and in-vitro 
experiments, these artifacts can serve as a source of contrast, enabling microvessels with an inner 
diameter below the spatial resolution of any medical imaging modalities to be visualized using a 
clinical MR scanner. For such experiments, micron-sized agglomerations of iron-oxide (Fe3O4) 
nanoparticles were injected in microchannels with internal diameters of 200 and 50 micrometers 
(µm) equivalent to a narrower artery or a larger arteriole, and down to a smaller arteriole 
respectively. The results show the feasibility of the proposed method for microparticle detection 
and the visualization of microvessels using a 1.5 T clinical MR scanner. It was confirmed that the 
method is reproducible and accurate at the sub-pixel level. 
4.2 Introduction 
 X-ray angiography is considered the method of reference for vasculature visualization.1,2 It is 
an invasive procedure that involves selective catheterization and contrast injection into blood 
vessels. This technique achieves a spatial resolution of ~200 µm. Although the technique 
provides the highest spatial resolution among all imaging techniques and modalities, it cannot be 
applied to the visualization of human arterioles with diameters smaller than ~200 µm.  
 MRI is a noninvasive technique that applies a radio frequency pulse to disturb the aligned 
nuclear spins and detects the resultant realignments following termination of the pulse. The spins 
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reorientation is tissue-dependent and is the source of contrast in MR images. MRI offers several 
advantages including absence of ionizing radiation, excellent soft tissue contrast and a relatively 
high spatial resolution. Conventional MR scanners at 1.5 T provide a spatial resolution of ~0.8 
mm. This value can be improved to ~0.5 mm for 3.0 T scanners.3  
 Preclinical imaging modalities have been shown to be able to produce resolutions required for 
resolving the microstructures of animal models. Yet, visualization of small human 
microstructures such as lymph nodes, cell clusters and microvascular networks remains beyond 
the resolution competence of the current clinical imaging modalities. Real-time drug delivery to 
tumor sites can benefit from microvasculature visualization through magnetic resonance 
imaging.4 The technique is based on therapeutic magnetic microcarriers (TMMC) steered and 
tracked using an upgraded MRI system. Metabolism of tumors depends on their 
microenvironment. The vascular network provides them with nutrients and, from a therapeutic 
perspective, could also be used to deliver anticancer drugs. The microcarriers are released and 
steering gradients are applied to guide the microcarriers towards a selected entry site of a 
capillary network. Prior to the intervention, it is essential that a 3D map of the local 
microvasculature around the tumor supports identification of the arterial delivery path. 
Angiogenesis and microvascular imaging is performed through quantification of the blood 
volume map and the vascular volume fraction in the region of interest (ROI) using 
superparamagnetic agents.5 This technique results in visualization of the microvessel density in 
the ROI. For specific detection (targeting) of macromolecules (in cellular imaging) and 
endothelial cells (in microvascular imaging), ligands such as antibodies, peptides and aptamers, 
are required to be conjugated to the MRI contrast agents to induce a hypo-intense signal in the 
vicinity of the non-targeted tissue.6-8 Angiogenesis imaging using clinical MR scanners have shed 
light onto microstructure characterization; nonetheless it is not appropriate for delineation of the 
microvessels in detail and in a 3D representation. 
 Due to their high magnetic susceptibility, magnetic materials cause inhomogeneity in the local 
magnetic field of the MRI system to an extent much larger than their size. The inhomogeneity 
appears in T2*-weighted gradient echo images in the form of a signal loss (hypo-intense signal). 
The signal loss degrades the quality of the MR images. However, this artifact can serve as a 
source of contrast. The amount of the signal loss is directly proportional to the susceptibility, the 
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total magnetic volume and the scan parameters. Therefore, susceptibility-based contrast provides 
a mean to visualize magnetic particles with volumes largely inferior to the spatial resolution of 
the imaging system. 
 The visualization of single particles through the susceptibility artifact has been applied to the 
cellular imaging. It has a large range of application in understanding the mammalian cell biology 
i.e., cell transplantation and for monitoring cell migration. Several studies have been performed 
to detect single cells using MRI.9-12 In order to detect single cells, high resolution MR images at 
an in-plane resolution of about 100×100 µm is obtained by using either ultra high field pre-
clinical MR scanners10-12 or custom-built gradient coils.13 But as far as we know, no techniques 
based on susceptibility artifacts have been applied for the visualization of smaller blood vessels. 
 In Ref 14, we showed that a single stainless steel sphere measuring 15 µm in diameter with a 
saturation magnetization of 207 emu g-1 can be detected in the images of a 1.5 T clinical MR 
scanner. It was shown that the disruptions of the magnetic field caused by the particle could be 
detected from a distance away at least as large as 70 times its own diameter.  
Our objective is to visualize microchannels having diameters smaller than the spatial resolution 
of the system. A 1.5T MR scanner and conventional RF coil arrays were used to detect individual 
ferrofluid microagglomerations. Microagglomerations can resemble the signal loss behavior of 
microparticles in an image. Each microagglomeration was composed of superparamagnetic 
magnetite nanoparticles (MNPs) suspended in carrier oil. A T-junction microfluidic device was 
used to generate ferrofluid microagglomerations 15 with a size allowing sufficient magnitude of 
the magnetic dipole to be detectable at the boundaries of the MR scanner’s voxel. 
In our previous studies, we investigated the detectability of a magnetic micropparticle within 
the constraints of clinical MR scanners using in-vitro and simulation experiments.14,16 Here, the 
application of the magnetic microagglomerations behaving like a microparticle in the 
visualization of the microvasculature is studied.  
 This article is organized as follows: The theory of the magnetic field created by the magnetic 
microagglomeration in the presence of an external field is described in section 4.3. Section 4.4.1 
describes an algorithm for the 3D reconstruction of the microvessels based on the detection of the 
micro-aggregations. Section 4.4.2 is dedicated to the in-vitro experiments on the 2D 
microchannels prior to concluding remarks in Section 4.5. 
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4.3 Theory 
 Due to the field inhomogeneity caused by their elevated susceptibility, magnetic particles 
induce a distortion in the MR images. The induced field inhomogeneity creates two forms of 
artifact in the MR images; geometrical distortion and echo shifting.17,18 Geometrical distortion is 
the misregistration of the spins' position caused by the field variations occurring during the 
frequency encoding. If Gx and Gx' represent the amplitude of the readout gradient and the 
background gradient caused by magnetic field inhomogeneity, respectively, spins residing at 
position x will be mapped to the apparent position x' :  
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Additionally, the presence of an extra gradient along the read-out direction results in a time 
shift in the gradient echo (GE) relative to the sampling window. A GE that is not centered in the 
acquisition window causes signal loss in an MR image. Owing to their 180° refocusing pulse, the 
echo shifting artifact is mitigated in the spin echo (SE) scans. Data reconstruction is performed 
on the basis of ideal echo time (TE) being the origin in the k-space. Therefore, the echo shift 
leads to a phase shift across the voxel upon Fourier transformation: 
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where ΔBz is the z-component of the field produced by the magnetic object and γ is the 
gyromagnetic ratio of the protons. If φΔ  equals 2π, or a nonzero positive integer multiple of 2π, a 
complete dephasing occurs and the voxel signal vanishes entirely. The field distribution induced 
by the magnetic microparticle (microagglomeration) at position r
!
 can be approximated by the 
magnetic fields of a dipole 19  
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where the magnetic dipole moment of the microparticle or microagglomeration having radius a 
and saturation magnetization Msat is: 
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Since the MRI’s homogeneous magnetic field (B0) magnetizes ferromagnetic and 
superparamagnetic particles to saturation (or very close to saturation), neither B0 nor the magnetic 
susceptibility difference is expressed in the magnetic field distribution equation. The normalized 
signal decay from a particle of homogeneous spin density (ρ) becomes: 
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 Equations 4-3 through 4-5 address the signal loss caused by the phase accumulation at the TE. 
However, GE images are influenced by both forms of artifacts. It has been shown that in GE 
images of conventional MR scanners echo shifting’s impact dominates that of a geometrical 
distortion. In Ref 12, image simulation was performed based on: i) geometrical distortion and 
echo shifting and ii) echo shifting only. Major deviations were observed in the results obtained 
from the high-resolution images (< 100 µm) of the high field MR scanners. Nonetheless, no 
significant difference was observed for image resolutions of > 200 µm. The artifact‘s position is 
expected to reflect the exact position of the microparticle or ferrofluid microagglomeration for 
microvessels’ imaging. 
Lengthening the TE is an evident approach to pronounce the dephasing effect in the GE 
sequences (see Eq. 4-2). It has been shown that the signal loss in GE sequences is independent of 
the strength, in-plane resolution, and orientation of the readout gradient.20 
4.4 Materials and Methods 
4.4.1 Simulation experiment 
 To simulate microagglomerations’ trajectory in microchannels, an algorithm was developed 
on the basis of the susceptibility artifact. The algorithm was then examined to understand its 
behavior in the absence of system nonlinearities. The echo shifting emerging from the phase 
accumulation at the TE (see Eq. 4-5) was used to simulate the susceptibility artifact. A 3D Y-
shaped microchannels were generated using random spatial coordinates. The microchannels fit in 
a volume of 4×4×4 cm3. The images were evaluated on a coronal and a transversal plane with a 
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slice thickness of 4 mm and a pixel spacing of 0.5 mm which are typical parameters for a 
conventional MR scanner. The diameter of the particles and the TE were set to 50 µm and 30 ms, 
respectively. The diameter of the channels was considered to be the same as the particles’ 
diameter. Microagglomerations were released, scanned and positioned along the trajectory. The 
position of the artifact reflects the exact position of the microagglomeration. The artifact has the 
shape of a four-leaf clover with two axes of symmetry in coronal and sagittal planes and is 
symmetric around the z axis (direction of B0) (FIG. 4-1A). As such, the position of the particle 
was determined by spotting the center of the artifact. The pixel representing the center (P) was 
calculated based on the weighted average of the pixels’ positions (Xk) in the region of interest 
(ROI). The intensity (Ik) of each pixel was used as the weight factor (Eq. 4-6). The result of this 
equation is known as the ‘’center of mass’’.21 When the particle fills more than one pixel, this 
equation provides an estimate of the particles position with sub-pixel accuracy.  
∑∑=
k
k
k
kk IIXP          (Eq. 4-6) 
 In the presence of a number of particles in the field of view (FOV), the shape of the 
susceptibility artifact varies based on the distance between the particles. In order to associate the 
position of a particle to the center of the produced artifact in the image, each signal void must 
represent a single microparticle. To meet this requirement, a minimum distance needs to be 
maintained between the particles. The shape and the amount of the susceptibility artifact for 
various spacing between the particles were studied in Ref. 16. The results implied that for a pair 
of identical particles with diameter d, the shape of the susceptibility artifact change when the 
particles are separated by more than 15×d and they become completely distinguishable when 
their distance reaches 40×d. However, for distances < 15×d the susceptibility artifacts generated 
by the two particles are nearly superimposed and the shape of the signal void is similar to that of 
a single particle. It was also shown that the obtained cut-off values are independent of the 
particle’s diameter and the image resolution. Therefore, in the current simulation a distance of 
30×d was used for particles spacing. This distance ensures visibility of individual particles.  
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Figure 4-1: Simulated transversal (left) and coronal (right) gradient echo images for a magnetic 
particle (A). Two different slices are shown in (B) Circled areas show complete signal loss which 
indicates the presence of a particle in each of the slices. Several slices were scanned within the 
volume of interest and scans were repeated for a number of times to ensure all of the particles are 
captured in the collected images. The third image from the top shows a complete signal loss 
indicating the presence of a particle in the image (C). 
 
Temporal resolution for tracking was set to the value used in a fast single slice GE sequence 
(~2 s). In an arteriole of 10 to 100 µm in inner diameter, the blood flow is approximately 1 
mm/s.22 Considering an acquisition time of 2 s., particles were displaced about 2 mm at the scan 
intervals. Several slices were scanned within the volume of interest and the scans were repeated 
for a number of times to ensure that all particles were captured in the collected images (FIG. 4-
1C). To position the particles, the artifacts with a complete signal loss (circled areas in FIG. 4-1B 
were selected from the collected images of each slice. Position of a particle along the third 
dimension is defined by the position of the scanned slice. 
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Figure 4-2 depicts the sagittal images obtained from the scans at different slices. At each scan, 
the coordinate of the particle was calculated as formerly described in Section 4.4.1. Figure 4-3 
illustrates the points reconstructed by using the transversal and the sagittal scans. The 
reconstructed points were compared with the original generated spatial coordinates to calculate 
the positioning error (Table 4-1). The obtained error values were averaged and expressed in the 
number of pixels. The error on the perpendicular axis of a particular plane was measured to be 
double the error calculated on the plane itself; axis z and x in transversal and sagittal planes, 
respectively. As the signal to noise ratio (SNR) decreases with a reduction of the slice thickness, 
the imaging voxel on the third dimension is always constrained by a minimum acceptable value.  
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Figure 4-2: Images obtained from the scans at different slices. At each slice a complete signal 
loss indicates the presence of a particle. 
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Figure 4-3: Simulated 3D channel (solid line) and reconstructed points (×) using sagittal (A) 
and transversal (B) scans.  
 
Table 4-1: Mean positioning errors expressed in the number of pixels (pixel size=0.5 mm) in 
reconstructed channels using sagittal and coronal scans. 
Imaging plane X Y Z 
Sagittal 2.02 ± 0.05 1.05 ± 0.06 1.07 ± 0.05 
Transversal 1.20 ± 0.06 1.3 ± 0.09 2.4 ± 0.11 
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4.4.2 In-vitro experiments 
 An oil-based ferrofluid (Ferrotec) was used to generate susceptibility-based contrast in MR 
images. The ferrofluid contained 10 % magnetite nanoparticles (MNP: Fe3O4) measuring 10 nm 
in diameter, 10 % oil soluble dispersant and 80% oil-based carrier liquid. Magnetic properties of 
the particles were measured with a Vibrating Sample Magnetometer (VSM) (EV9, Microsense) at 
room temperature. The saturation magnetization was measured at 68 emu g-1 and it was 
confirmed through the hysteresis curve that the particles were saturated at 1.5 T. 
 In order for the nanoparticles to create sufficient disruption in the magnetic field and become 
detectable in MR images, oil-in-water micro-drops were used. The size-controlled micro-drops 
consisting of microagglomerations of MNPs were generated by a) a T-junction microfluidic 
device and b) suspenstion of oil in water in the presence of a surfactant. The 
microagglomerations generated by method a were injected in a 2D Y-shaped microchannel of 
200 µm in diameter and those produced by method b were injected in a capillary of 50 µm in 
diameter. 
 A 2D microfluidic chip was created from poly-methylmethacrylate (PMMA) fabricated by 
micro-milling (LPKF Protomat) and high-pressure thermal sealing technique. The microfluidic 
included a T-junction and a Y-shaped channel of 200 µm in diameter (FIG. 4-4A). The T-
junction was used to generate microagglomerations of MNP based on the cross flowing rupture 
technique 15 and the Y-shaped part was used for imaging purposes. The continuous phase (water 
+ surfactant) was introduced from the vertical channel and the dispersed phase (oil-based 
ferrofluid) was introduced from the perpendicular channel. Sodium Dodecyl Sulfate (SDS) of 0.1 
wt% was added into the water phase to control the interfacial tension between the two phases. 
The size and the distance of the droplets were controlled by the flow rate of the two introduced 
phases. To obtain droplets of ~ 200 µm in diameter distanced apart at ~ 6 mm, flow rates were 
fine tuned at 30 µL/min and 1 µL/min for the continuous and the dispersed phases, respectively 
(FIG. 4-4B).  
 The other method opted to generate micrometer-sized ferrofluid microagglomerations, was 
based on the formation of water-oil micro-emulsions. The technique involves dissolving an 
aqueous phase into an oil phase in the presence of a surfactant to stabilize the suspension. As 
such, an emulsion of ferrofluid droplets was suspended in water in the presence of 0.1 wt% SDS. 
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The average size of obtained emulsion spherical droplets was measuring at 50 µm ± 20 (FIG. 4-
5A). 
 
Figure 4-4: 2D microfluidic chip made of PMMA included a T-junction for micro-drop 
generation and a Y-shaped channel of 200 µm in diameter for imaging purposes (A). The T-
junction was used to generate microagglomerations of nanoparticles based on the cross flowing 
rupture technique (B). 
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 The particles were injected in a capillary of 50 µm in diameter (FIG. 4-5B). To mimic the human 
body relaxation times, both the microfluidic and the capillary were suspended in the middle of a 
solution made of gelatin and Sodium Chloride. The extremities of the chip were kept out of the 
gelatin to minimize the susceptibility artifact in the images caused by the accumulation of 
particles in the outlets and the inlets. The capillary was suspended in the gelatin in a 3D U-shape. 
The MR imaging was performed using a 1.5T (Magnetom Siemens) MRI system. Images were 
acquired with the standard 8 channel head coil. The injection was paused during the imaging 
process. Two different MRI sequences were used; gradient echo (GE) (TR = 500 ms, TE = 10 
ms, slice thickness=4mm, resolution = 2562 and pixel spacing = 0.6 × 0.6 mm) and balanced 
gradient echo (TrueFISP) (TR = 4.7 ms, TE = 2.6 ms, slice thickness = 4 mm, resolution = 2562 
and pixel spacing = 0.6 × 0.6 mm). The former provides the maximum delectability for magnetic 
particles by pronouncing the signal loss and the latter provides a rapid acquisition time allowing 
for real-time imaging.  
 
Figure 4-5: Emulsions of ferrofluid droplets were suspended in water in the presence of 0.1 wt% 
SDS to generate stabilized droplets. The average size of obtained emulsion spherical droplets was 
measured at 50 µm ± 20 (C) (A) Oil-based ferrofluid microagglomerations injected in a capillary 
tube measured 50 µm in diameter (B). 
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Figure 4-6 shows the MR images of the 200 µm channels with GE (A) and TrueFISP (B) 
sequences. The microagglomerations measured 200 µm in diameter. The acquisition times for 
coronal images (4mm thick, 256×256) were 176 and 2.1 seconds for GE and TrueFSIP 
sequences, respectively. The susceptibility artifacts were detected in the channels and the shape 
of the artifact corresponds to the theory.  
 The MR imaging was executed at several different time instants. At each iteration center of the 
artifacts, points (x), were measured (FIG. 4-7A) and compared to the actual values (FIG. 4-7B). 
Absolute errors (xreal-xmeasured) are expressed in the number of pixels in Table 4-2. Repeated 
measures analysis of variance (two-way ANOVA) suggested good reproducibility across the 
iterations (F(14,84)=0.4997,P=0.9272), and also good repeatability within each data set 
(F(6,84)=1.449, P=0.2058). 
 The visibility of the 50 µm capillary was investigated in the experiments as shown in FIG. 4-8. 
The capillary was injected with microagglomerations measuring 50±20 µm in diameter (see FIG. 
4-5A). Figures 4- 8.A through 4-8.D show images captured with the GE sequence, multi slice 
scan with an acquisition time of 174 sec, and FIG. 4-8.E shows the image captured with the 
TrueFISP sequence and an acquisition time of 2.1 sec. The echo time of the GE scans for the 200 
µm channel was set to 10 ms. This value was changed to 50 ms for 50 µm capillary scans to 
increase the size of the artifact in the images and thus to improve their visibility. However, the 
particles are hardly visible in the TrueFISP images. The capillary was reconstructed based on the 
proposed algorithm. At each slice the coordinates of the artifacts’ centers were calculated and 
collected to build a 3D distribution of the capillary. The reconstructed image is shown in Figure 
4-9. 
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Figure 4-6: Images of the 200 µm channels imaged by a 1.5 T clinical MR scanner using a GE 
sequence (A) with the following imaging parameters: TR=500ms, TE=10 ms, slice thickness=4 
mm, resolution = 256×256, pixel spacing =0.6×0.6 mm2 (A) and a TrueFISP sequence (B) with 
the following imaging parameters: TR=4.7ms, TE=2.6 ms, slice thickness=4 mm, resolution = 
256×256, pixel spacing =0.6×0.6 mm2. 
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Table 4-2: Absolute errors expressed in the number of pixels for reconstructed points from the 
MR scans acquired at seven different time instants. 
Repetition 
No. 1 2 3 4 5 6 7 
Po
si
tio
ni
ng
 e
rr
or
 o
f t
he
 r
ec
on
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ru
ct
ed
 p
oi
nt
s  
(n
=1
5)
 
ex
pr
es
se
d 
in
 th
e 
nu
m
be
r 
of
 th
e 
pi
xe
l 
1.028 1.043 0.311 0.904 0.756 0.569 0.024 
1.249 0.866 0.100 0.507 0.311 1.115 0.321 
0.928 0.344 0.134 0.679 0.435 0.469 0.536 
0.493 0.493 0.579 0.091 0.684 0.053 1.225 
0.432 0.244 0.455 0.392 0.870 0.029 0.636 
1.021 0.144 0.144 0.129 0.512 0.120 0.517 
0.823 0.627 0.297 1.063 0.823 0.067 0.067 
0.962 0.038 0.014 0.234 0.277 1.133 0.588 
0.966 0.655 0.411 0.287 0.799 0.780 0.694 
0.718 0.072 0.387 0.411 0.966 0.804 0.172 
0.344 0.636 1.220 0.995 0.225 0.282 0.383 
0.239 0.488 0.679 0.239 1.138 0.828 0.076 
0.244 1.406 0.679 0.698 1.076 0.579 0.301 
0.550 1.258 0.462 0.488 0.182 0.330 0.268 
0.88 0.262 0.862 0.277 0.713 1.421 0.231 
Mean 0.725 0.572 0.449 0.493 0.651 0.572 0.403 
Standard 
deviation 0.319 0.421 0.320 0.311 0.311 0.437 0.312 
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Figure 4-7: The measured points shown as * determined from the center of the artifacts (A) are 
compared to the real values shown as solid lines (B) to calculate the absolute measurement errors 
(Table 4-2). 
4.5 Discussion 
 The simulation results proposed promising accuracy in 3D reconstruction of the 
microchannels. Combining the reconstructed points generated by the scans of two different 
planes ex. transversal and coronal can compensate for the error difference on the third dimension.  
 The 50 µm capillary injected with the microagglomerations is hardly visible in the TrueFISP 
image. FIG.4-6E displays the limitation of a 1.5 T clinical MR scanner in real-time visualization 
of iron oxide microagglomerations. The results shown in figures 4-5 and 4-6 demonstrate the 
feasibility of the proposed method in microagglomerations positioning. The average error was 
less than a pixel for all the seven trials (standard deviation=0.155). The results confirm a high 
reproducibility and repeatability across the repetitions and within each group.  
 
  
 
 
60 
 
Figure 4-8: Images of the 50 µm capillary imaged at different slices (A-D) by a 1.5 T MR 
scanner using a GE sequence (A) with the following imaging parameters: TR=500ms, TE=50 ms, 
slice thickness=4 mm, resolution = 256×256, pixel spacing =0.6×0.6 mm2 (A) and a TrueFISP 
sequence (E) with the following imaging parameters: TR=5.2ms, TE=2.6 ms, slice thickness=4 
mm, resolution = 256×256, pixel spacing =0.6×0.6 mm2. 
 
 
Figure 4-9: The reconstructed capillary is shown by positioning signal voids in different slices 
shown in FIG. 4-6. At each slice the coordinates of the artifacts’ centers were calculated and 
collected to build a 3D distribution of the capillary. 
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4.5.1 Iron-oxide nanoparticles 
 Susceptibility-based negative contrast provides a mean to amplify the effect of a particle in the 
MR images whereas its volume is largely inferior to the spatial resolution of the system. In this 
study, the application of the susceptibility artifact is suggested to map the microchannels, the 
limited resolution of which falls beyond the adequate ranges of the clinical imaging modalities. 
Contrast agents have been widely used in MRI to improve blood vessel visualization. 
Paramagnetic agents (ex. gadolinium ion) produce positive contrast by accelerating spin-lattice 
relaxation. Superparamagnetic agents such as iron-oxide nanocrystals (SPIO) produce negative 
contrast by accelerating spin-spin relaxation. SPIOs have a number of attractive qualities that 
make them a promising alternative to gadolinium-based contrast agents. Depending on their size 
and coating, they benefit from biocompatibility, long circulating half-life and the possibility of 
clearance from the blood circulation through the reticuloendothelial system.23 Due to their unique 
properties, they have been widely investigated for biomedical applications such as angiogenesis 
imaging in tumors and molecular-cellular imaging.24,25 Clinical MR scanners can image density 
of the microvessels through quantification of the blood volume map and vascular volume fraction 
in the region of interest. However, the images are not capable of providing a detailed 3D map of 
the microvessels.  
4.5.2 Microagglomerations of nanoparticles 
In this study, the application of microagglomerations composed of nanoparticles is suggested 
for microstructures’ visualization. Magnetic moment of a micrometer-sized particle is a function 
of the saturation magnetization and the volume of the particle. The advantage of using 
microagglomerations is the concentrated mass of a magnetic material in a small micro-volumetric 
space. Consequently, microagglomerations can resemble the signal loss behavior of 
microparticles in an image. The symmetric property of the microagglomerations’ signal loss can 
be used to track them along a trajectory. Jointly, the biocompatibility and biodegradability 
characteristics of the iron-oxide nanoparticles enhance their application. To our knowledge, oil-
based ferrofluid has never been used experimentally as a MRI contrast agent. However, water in 
oil emulsions composed of iodized oil and an aqueous solution carrying anti-cancer drugs is 
widely used for treatment of the hepatic tumors.26,27 
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4.5.3 Droplet generation 
Emulsions contain droplets with varying diameters. Microfluidic devices are widely used to 
generate monodisperse population of micro-drops. One of the most frequently applied 
microfluidic devices for droplet generation are ‘T-junctions’. The droplet formation is based on 
the breakup of a continuous phase of one liquid caused by shear from the cross flow of a second 
immiscible phase. The advantage of using a microfluidic device is the precise control over the 
formation of the immiscible fluid segments. The size of the droplets and their spacing depend on 
the geometrical dimension of the channels as well as the flow rates of the dispersed and 
continuous flows.28,29 As described before, the size of the artifact varies as a function of the 
droplet diameter. If the distance between the droplets drops below ~15 times their diameter, the 
artifact generated by the individual particles are almost entirely superimposed and the shape of 
the signal loss resembles that of a single particle. In the presence of several particles in the FOV 
with a spacing < 15×d, the artifact in the images will be a large continuous signal loss through 
which, positioning of the particles is impossible. Therefore, it is essential to keep a minimum 
distance between the particles. Injection of monodisperse equidistant microagglomerations can be 
performed using a microfluidic device.  
 Magnetic particles have a strong tendency to agglomerate in the presence of the MRI magnetic 
field. This makes their injection with a controlled spacing challenging. Encapsulating the 
particles with degradable polymers prevents them from being agglomerated. However, a 
relatively large shell is needed to maintain the minimum distance between the particles. This 
results in larger particles incapable of reaching the microvasculature system. To overcome this 
problem, we generated the droplets in a microfluidic device inside the MRI bore where there is a 
homogeneous magnetic field and no magnetic force is exerted on the particles. However, the in-
vitro experiment could not follow the proposed algorithm in reproducing the blood flow rate.  
 In the simulation model, the flow rate in the arterioles (1 mm/sec) was used. However, 
limitations of the injection system in the in-vitro experiments prevented us from reproducing the 
flow rate of 1 mm/sec in the channels. The injection pumps were placed at the extremity of the 
MRI bed to avoid interaction between the MRI’s magnetic field and the metallic parts of the 
pumps. Therefore, tubes required to deliver the ferrofluid and the water, were extended along the 
MRI bed towards the center of the bore where the microchannels were located. A relatively high-
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pressure gradient produced along the tubes limited the lower value of the flow in the channels. To 
cope up with this, the injection was paused during the imaging sequences. This pause prevented 
from the observation and study of the motion artifact resulted from movement of the particles in 
the images. 
 Signal void is used as an indication of the presence of iron oxide microagglomerations. 
Nevertheless, the presence of different sources of negative contrast in the human body encumbers 
the distinction of the negative contrast associated with the magnetic particles. Application of 
positive contrast approaches based on modified pulse sequences or post-processing methods 30,31 
can improve the visibility of the magnetic particles in the human body.  
 At the capillary level, multiple vessels are located within a single voxel. Consequently, 
visualization of the capillary networks applying the proposed technique becomes more 
challenging. In Ref 12, the possibility of subvoxel tracking is demonstrated. This technique may 
be applied to find the relative position of the detected particle within a voxel.  
4.6 Conclusion and future work 
A method is proposed to map microchannels using a clinical MR scanner. The method is based 
on real-time tracking of the magnetic microagglomerations. In the proposed technique, the 
information of time discrete scans is extracted and assembled to build a 3D distribution of the 
microchannels. Microagglomerations of iron-oxide nanoparticles proved to be a promising 
candidate for reproduction of the microparticles’ effect and improvement of their visibility in the 
MR images.  
 The variation analysis of the results confirmed the reproducibility of the method and proved 
the accuracy of the point reconstruction of the susceptibility artifacts to be at the sub-pixel level. 
As the next step, we intend to validate our method by mimicking the microvasculature blood flow 
in the channels. To avoid using extended tubes along the MRI bore and to deliver the immiscible 
liquids, a new microfluidic design with a built-in reservoir may be applied. Properly spaced 
droplets will be accumulated in this reservoir before positioning the setup in the MRI bore. The 
signal loss induced by the droplets shall open numerous future possibilities for the application of 
clinical MR scanners in the microstructure and microvessel imaging. 
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5.1 Abstract 
Being able to visualize blood vessels with an inner diameter of less than 150 µm is the present 
limit of modern medical imaging modalities and it becomes an important issue to advance state-
of-the-art medical imaging, diagnostics, surgery, and targeted interventions. In cancer therapy, 
such capability would provide the information required for new delivery methods such as 
Magnetic Resonance Navigation (MRN) to navigate therapeutic agents along a planned trajectory 
deeper in the vasculature and hence, closer to the region to be treated for enhancing the 
therapeutic index. To demonstrate the possibility of gathering images of microvascular networks 
dynamically and beyond the limitation of medical imaging modalities, the susceptibility artifact 
was used as the contrast mechanism in MRI to detect magnetic microagglomerations of iron-
oxide nanoparticles (150 ± 20 µm in diameter) as they were injected in a 2D synthetic 
microvascular network. Magnetic entities cause susceptibility artifacts in the images by 
disrupting the MRI’s homogeneous magnetic field (B0) in a much larger scale than their actual 
size. The position of the artifact reflects the position of the aggregations in the vascular system. 
The calculated positions of discrete-time scans were extracted and assembled to build up the 
distribution of the vascular network. The results suggest that this method could be used to gather 
images of blood vessels beyond the spatial resolution of clinical medical imaging modalities with 
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a measured average error confirmed on a 2D reconstruction of the microvessels of approximately 
half of a pixel’s size. 
5.2 Introduction 
The visualization of vascular networks is of prime importance for several medical interventions 
including but not limited to Magnetic Resonance Navigation (MRN).1-3 In this technique an 
upgraded clinical MRI scanner is used to navigate untethered therapeutic microcarriers along a 
pre-planned trajectory. The technique allows the delivery of a higher dose of therapeutics to the 
targeted region while decreasing the level of toxicity by minimizing systemic circulation of the 
drug. To take full advantage of MRN, the navigable therapeutic agents must be able to transit 
through thinner blood vessels which increases the demand for medical imaging modalities with 
higher spatial resolution. The structure of the local vascular network determines the proper MR-
navigation sequences to achieve the best therapeutic outcomes. 
X-ray angiography is considered the method of reference in vasculature visualization with a 
spatial resolution of ~0.15 mm.4 Conventional 1.5 T clinical MRI scanners can provide a spatial 
resolution of approximately 0.8 mm, improving to 0.5 mm using 3 T clinical scanners.5 Current 
clinical medical technologies are not yet suitable to visualize arterioles with a typical inner 
diameter varying from approximately 150 µm down to 50 µm. But in MRI, susceptibility-based 
negative contrast provides a mean to amplify the effect of a magnetic particle, whereas its 
dimension is significantly inferior to the spatial resolution of the system. In the presence of the 
MRI’s homogeneous high strength magnetic field, particles become magnetized and as a result, 
an inhomogeneity is induced in the B0 field. The inhomogeneity appears as a signal loss artifact 
in T2*-weighted Gradient Recalled Echo (GRE) images. The artifact can serve as a source of 
contrast by depicting the presence and the location of a magnetic volume in a micrometric scale.  
A large number of studies have been carried out to produce high resolution images of 
microvessels. Application of images in the 100 µm range resolution, generated by preclinical 
scanners has now become a routine in small animals, cellular and molecular imaging.6-9 Clinical 
scanners can identify microvessels through quantification of the blood volume map and vascular 
volume fraction in the region of interest.10-12 In some other studies,13-15 upgraded custom 
receiving coils have been designed to image micro-structures over a relatively small region (2-5 
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cm2). However, clear and detailed imaging of arterioles in the order of 50 to 200 µm using 
clinical scanners remains to be further developed. 
In an earlier study, we showed that using a clinical 1.5 T MRI scanner, a single ferromagnetic 
particle measuring 15 µm in diameter could be detected in T2*-weighted GRE images.16 The high 
magnetic susceptibility of the ferromagnetic materials creates a high inhomogeneity in the MRI’s 
main magnetic field and consequently, these particles become duly traceable in MR images. 
Adversely, ferromagnetic materials tend to maintain a high remanent magnetization, limiting 
their clinical applications. On the contrary, superparamagnetic particles have unique properties, 
making them interesting options to be used as MRI contrast agents. They do not retain the net 
magnetization upon the removal of the magnetic field. Furthermore, their small size (5-20 nm) 
helps them to easily pass through the body’s capillary network and be cleared from the 
circulation through the phagocytic function of the reticuloendothelial system.17  
In a previous study, we showed the application and limitations of microagglomerations of iron-
oxide nanoparticles to gather images of micro-channels having internal diameters of 200 and 50 
µm. However, due to a strong interaction between the magnetic nanoparticles and B0, that is 
present outside the MRI bore, we failed to reproduce the blood flow rate inside the channels.18 
Thus, the injection was paused during the imaging sequence and this pause prevented us to study 
the accuracy of the technique in positioning moving particles.  
The purpose of this study is to improve the technique by mapping a synthetic microvascular 
network dynamically instead of statically through the injection of iron-oxide nanoparticle 
agglomerations and to subsequently scan them in real-time using a rapid MRI sequence. The 
position of the artifact reflects the position of the agglomerations in the vascular system. The 
calculated positions of discrete-time scans are extracted and assembled to build up the 
distribution of the vascular network.  
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5.3 Materials and Methods 
5.3.1 Distorted patterns of magnetic materials in MRI 
In MRI, the spatial encoding is performed by applying a magnetic gradient field that varies 
linearly in space. The magnetic gradient assigns a unique precession frequency at several 
locations along its direction.  
In GRE images, due to the absence of the 180˚ refocusing pulse, an echo shifting effect should 
also be taken into account. Therefore, the influence of a position dependent phase term (
TEB..Δ−=Δ γϕ ) is added to determine the position of the spins. The normalized signal decay due 
to a magnetic particle of homogeneous spin density ρ is given by: 
( ) rde
s
s TErBi
V
3
0
0
!
Δ−∫= ρ          (Eq. 5-1) 
The additional dephasing dampens the echo signal which in turn can lead to a complete signal 
loss in the images. As the result of the rephasing pulse, this effect is mitigated in Spin Echo (SE) 
sequences. GRE artifacts are generally much more pronounced than SE artifacts. 
The dephased volume resulting from the presence of a magnetic particle in B0 is shown in 
Figure 5-1. The magnetic field induced by a particle was simulated by that of a dipole: 
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where µ0 = 4π × 10-7 is the permeability of the free space, r!  is the position vector, and m!  is the 
magnetic dipole moment of the microparticle or microagglomerations of radius a and saturation 
magnetization of satM
!
. The MR images of a magnetic particle are similar to the projections of the 
dephased volume.  
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Figure 5-1: simulated dephased volume caused by a magnetic particle (see equation 2). 
5.3.2 Synthetic vascular network 
A mirofluidic chip with a 2D vascular network was created from polymthylmethacrylate 
(PMMA) using a micro-milling machine (LPKF Protomat). The chip was sealed using high-
pressure thermal sealing technique (LPKF Multipress II). The vascular network was designed to 
have an inlet channel branching into eight smaller channels in a three-stage division (Figure 5-
2a). The branching structure in mammalian vascular networks is evolved with an optimum 
arrangement for blood flow. At each bifurcation the diameter of the branching segment is reduced 
in size. The relationship between the diameter of the parent vessel (d0) and that of the daughter’s 
(d1) is known as Murray’s law ( 31
3
0 2dd = ).
19 In our experiment, the diameter of the smallest 
segment was set to 150µm in diameter.  
Blood vessels are hydrophilic on the surface. Conversely, PMMA is strongly hydrophobic. In 
order to mimic the wetting property of a blood vessel, the surface of the channels was coated with 
a thin layer of Silicone Dioxide (SiO2) (~250 nm). Figure 5-2b depicts the effect of SiO2 coating 
on the wetting property of the surface. 
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Figure 5-2: (a) Schematic illustration of the T-junction, built-in reservoir and the delivery 
artery pattern. The dimension of the vascular network and the diameter of the branching segments 
are shown. (b) The effect of the surface treatment using SiO2 on the wetting property of PMMA. 
5.3.3 Microagglomeration of iron-oxide nanoparticles 
An oil-based ferrofluid (Ferrotec) comprising of iron oxide (Fe3O4) nanoparticles measuring 
10 ± 2nm in diameter was used to generate susceptibility based contrast in MR images. The 
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ferrofluid contained 10% Fe3O4 particles, 10% oil soluble dispersant and 80% oil based carrier 
liquid. Magnetic moments of the particles were measured using a Vibrating Sample 
Magnetometer (VSM) (EV9, Microsense). The saturation magnetization was measured at 68 
emu/gr and through the hysteresis curve it was confirmed that the particles were saturated at 1.5 
T. Oil in water droplets were generated to produce a concentrated mass of magnetic particles 
(microagglomerations) in a small micro-volumetric space. A T-junction geometry was included 
at the entry of the vascular network to generate the microagglomerations. The continuous phase 
(water + surfactant) was introduced from the vertical channel. Sodium Dodecyl Sulfate (0.1 wt 
%) was added into the water phase to lower the interfacial energy and to stabilize the formed 
droplets. A microliter syringe (Hamilton Company, Model 7000.5) with a total volume of 0.5 µL 
was used to inject very small quantities of ferrofluid (~0.01 µL) through the perpendicular 
channel (Figure 5-2a). The breakup of the continuous phase is caused by the shear from the 
immiscible oil-based cross flow.20-22 
Magnetic particles have a strong tendency to agglomerate in the presence of B0. As such, a 
minimum distance between the generated microagglomeration should be maintained to avoid the 
dipole-dipole interaction. The minimum value of the spacing depends on the volume and the 
saturation magnetization of the particles. A simulation model was developed to identify the 
minimum distance between the microagglomeration of iron-oxide nanoparticles based on their 
magnetic and geometric characteristics (see equation (1)). As shown in the figure 5-3, a 
microagglomeration pair identical in diameter (D) and saturation magnetization starts to appear 
separated when their distance reaches 30D. 0.01 µL of ferrofluid in volume forms a sphere of ~ 
250 µm in diameters. Therefore, to avoid dipole-dipole interactions, a minimum distance of ~ 7.5 
mm should be maintained between the aggregations. Figure 5-3 presents the signal intensity of 
the simulated image of particles of different diameters at different spacing varying from 1D to 
90D. As the artifact’s shape begins to change, the signal intensity grows in size. At distances of 
30D and higher, the signal remains nearly constant implying the absence of an interaction 
between the particles and thus the visibility of individual particles in MR images.  
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Figure 5-3: Simulated GRE signal intensity as a function of the distance between the particles 
on the coronal plane. The distance is labeled by multiples of the particles’ diameter (D). The 
curve labels represent the diameter of the particles in micrometers. The simulated coronal images 
of two identical iron-oxide microagglomerations with a saturation magnetization of 68 emu/gr 
and a diameter of 150 µm are shown. 
 
A built-in tortuous reservoir was added next to the T-junction and prior to the vascular network 
to collect the entire microagglomeration generated (Figure 5-2a). The aggregations were pushed 
forward inside the vascular network by injecting water and surfactant solution throughout the 
imaging sequence. 
5.3.4 MR imaging 
The microfluidic was suspended inside a solution comprised of gelatin and sodium chloride to 
mimic the relaxation times of the human body. The extremities of the microfluidic were kept out 
of the solution for an easy access to the injection site and to minimize the susceptibility artifact in 
the images caused by the accumulation of nanoparticles in the microfluidic’s outlet (Figure 5-4).  
The coefficient multiplied by the diameter
1-
(S
/S
0)
  
 
 
75 
 
Figure 5-4: The suspended microfluidic solution comprised of gelatin and sodium chloride 
with the injected microagglomerations. 
5.3.5 Image processing 
In order to transform the different sets of data obtained from the several repetitions of the 
experiment into a single coordinate system, three small holes with known coordinates were added 
on the microfluidic chip. The known coordinates were also used to align the theoretical model on 
the MR images and to estimate the measurement error.  
The position of the artifact represents the position of the microagglomerations. Susceptibility 
artifact in gradient recalled echo images creates a four-leaf clover shape on the sagittal and 
coronal planes and a circle shape on the transversal planes (Figure 5-1).  
Particles were localized based on "Center Of Gravity" (COG) of the artifacts. COG is a sub-
pixel precession estimate of the object’s center.23,24 The coordinates representing the center were 
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calculated based on the weighted average of the pixel’s positions (Xk) in the field of view, 
whereas, the intensity of each pixel (Ik) was used as the weight factor ( ∑∑
k
k
k
kk IIX ). 
The artifacts center points were determined and compared to the actual positions. Accordingly, 
the absolute measurement error was calculated.  
5.4 Results and Discussion 
The experiment was repeated twice. At each replication, multiple images were acquired while 
injecting the microagglomeration into the vascular network using a multi-shot True FISP 
sequence with the following imaging parameters: TR = 4.23 ms, TE = 2.12 ms, pixel spacing = 
0.83 ×0.83 mm2, imaging matrix = 192×192 and slice thickness = 8 mm. The scanning time for a 
single image was 1.01 s. The first and the second trials yielded 70 and 114 images, respectively. 
The signal voids of the images were visually identified and for each void the center of gravity 
was calculated. Particles were localized using coordinates of the center of gravity. 251 and 320 
coordinate pairs were obtained from the first and the second trials, respectively. Figure 5-5 shows 
a number of consecutive images obtained from the second trial. The actual pattern of the vascular 
network used in the experiment is superposed on the images to facilitate comparison. To 
accurately superpose the pattern, reference points were placed on the microfluidic chip to apply 
rigid registration. Figure 5-6a shows the measured points from the first and second trials 
superposed on the vascular network’s pattern. The data at each segment were fit based on a first-
degree polynomial equation and the estimated vascular network was obtained (Figure 5-6b). 
The calculated coordinates were compared with the actual pattern to estimate the positioning 
error. Mean positioning errors for the first and the second trials are presented in Table 5-1. 
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Figure 5-5: Consecutive images obtained from the second trial. The actual pattern of the 
vascular network is superposed on the images by applying rigid registration to facilitate the 
comparison. 
 
Table 5-1: Mean measurement errors of the first and second trials 
Positioning error Trial #1 Trial #2 
Mean (mm) 0.394 0.492 
Standard deviation 
(mm) 
0.227 0.254 
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Figure 5-6: The measured points from the first (×) and second (o) trials superposed on the 
vascular network’s pattern. (b) The acquired data at each segment were fit based on a first-degree 
polynomial equation and the estimated vascular network was obtained. 
 
This paper discusses and verifies the accuracy of a method proposed for visualization of 
microvessels (150 µm in diameter) using a clinical 1.5 T MRI scanner and a standard 8-channel 
head coil. The susceptibility artifact was used as the contrast mechanism to detect magnetic 
microagglomerations of iron-oxide nanoparticles. GRE sequences are effective as the contrast is 
the result of the dephasing water near the aggregations. The fast imaging with steady-state free 
precession (true FISP) based on gradient recalled echo is a fast sequence that achieves a scanning 
time of 1 sec per slice with a high signal to noise ratio and a high sensitivity to field 
inhomogeneity. These characteristics of the sequence make it a proper choice for dynamic 
tracking of magnetic particles. Here, we are showing the possibility of visualization of a 
microvascular network spread over an area of 3.6×3.6 cm2. Imaging is performed over an 
approximately 16×16 cm2 FOV, using typical imaging parameters such as a pixel size of 
0.83×0.83 mm2. The results suggest an accuracy of the 2D reconstruction of the microvessels 
characterized by a measured average error of approximately half of a pixel’s size. The calculated 
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positioning error implies that two adjacent vessels distanced at 0.44 mm are distinguishable in 
MR images using the proposed technique.  
Figure 5-6 presents the distribution of the measured coordinates ensemble superposed on the 
actual pattern. As shown, the distribution is not uniform implying non identical pressure 
gradients across the different branches. At the micrometric scale, a small difference in the 
geometry of the symmetric channels leads to a considerable imbalance in the pressure gradient 
inside the channels. The lack of a uniform distribution of the measured points can be caused by 
the imperfections in the fabrication process.  
A method is proposed to map microvascular network in real-time using a clinical MR scanner 
and a standard receiver coil. The results proved the accuracy of the reconstruction of a 2D 
synthetic microvascular model to be at the sub-pixel level. To our best knowledge, it is the first 
time that micrometric magnetic volumes are being used as a contrasting mechanism to map 
microvasculature in real-time. A next potential step of this study would be to validate the 
technique in a 3D microvascular model. 
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6.1 Abstract 
Visualization of small blood vessels feeding tumor sites provides important information on the 
tumors and their microenvironment. This information plays an important role in targeted drug 
therapies using magnetic gradients. However, complex microvascular networks cannot be 
resolved using current clinical imaging modalities. To solve this problem, a method is presented 
for 3D mapping of vascular networks based on the magnetic susceptibility artifact. Micron-sized 
agglomerations of Magnetite nanoparticles were injected in a 3D phantom vascular network and a 
fast multi-slice multi-acquisition MR sequence was applied to track the agglomerations along 
their trajectories. The susceptibility artifact in the images indicates the presence and the position 
of the agglomerations. The calculated positions through multiple images were assembled to build 
up the 3D distribution of the vascular network. The results suggest that the technique can be used 
for reconstruction of blood vessels beyond the spatial resolution of clinical medical imaging 
modalities at sub-pixel accuracy. 
Index Term—MRI, Magnetic susceptibility contrast, Magnetite nanoparticles, 3D 
reconstruction. 
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6.2 Introduction 
Visualization of the vascular network leading to tumoral sites offers the potential to 
significantly improve targeting of agents loaded with magnetic nanoparticles and therapeutics 
that can be navigated using a method known as magnetic resonance navigation (MRN).  MRN 
relies on magnetic resonance imaging (MRI) to induce a steering force on the magnetic 
nanoparticles, magnetized to saturation in the presence of the strong homogeneous magnetic field 
(B0) of the MRI scanner, to direct them toward a targeted area such as a tumor site with high 
efficacy [1-3]. Subsequently, the magnetic gradient coils of the scanner are used to induce a 
steering directional force on the microcarriers. The direction and the time at which the gradients 
are applied are determined based on the ability to determine the local vasculature leading to the 
targeted physiological area. However, the navigation in thinner vessels is limited by the spatial 
resolution of medical imaging modalities. 
Indeed, poor spatial resolution and/or low penetration depth of the current clinical imaging 
modalities are the major limitations in resolving microvascular networks. Amongst all clinical 
imaging techniques, digital subtraction angiography provides the highest spatial resolution of ~ 
180 µm and is considered as the reference method in angiography [4, 5]. However, the approach 
provides 2D images and it involves the application of an iodinated contrast agent which is 
potentially nephrotoxic. Color vascular ultrasonography together with micron-sized bubble 
contrast agents provides a spatial resolution of ~ 200 µm with a relatively poor penetration [6]. 
This limits the application of ultrasound imaging to superficial microvasculatures. Computerized 
tomography angiography can provide details of the vascular tree in small arteries in a 3D fashion. 
It has a limit of approximately 400 µm for vessel detection [7]. 
MRI is a noninvasive imaging technique with the ability to visualize soft tissues of the 
human’s body at any depth using typical birdcage receiver coils. Clinical scanners (1.5 and 3.0 T) 
provide an in-plane resolution of ~ 400 µm [8]. Custom designed coils can be used to improve 
the spatial resolution of the MR images. Microvessels as small as 100 µm in diameter can be 
resolved using home-built surface coils [9, 10]. However, the penetration depth of such coils is 
limited due to a quick drop in the signal uniformity, restraining their applicability to small 
animals or skin microvasculature [11,12].  
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All these approaches fail at providing a means to map vascular networks beyond the resolution 
of clinical medical imaging. As such, to compensate for a lack of spatial resolution, the signal 
generated by contrast agents could be amplified to a level sufficient to be detected by the imaging 
system. Magnetic volumes disrupt the B0 field of a clinical MRI scanner in a much larger scale 
than their actual size. In [13], we showed that the disruption of the magnetic field caused by a 
magnetic particle saturated in B0 could be detected from a distance of as far as 70 times its own 
diameter. This disturbance appears in the form of a signal void in MR images reflecting the 
presence and the location of the magnetic particle.  
Compared to the nanofabricated contrast agents (superparamagnetic particles) used in MRI, 
micrometer-sized agents can benefit from higher magnetic moments. Based on an equivalent 
amount of magnetic material, micrometer-sized particles have up to 50% higher relaxivity [14], 
creating a significantly higher visibility in MR images. The signal loss caused by magnetic 
microparticles forms a four-leaf clover in coronal and sagittal planes, and a circle in the 
transversal plane [15, 16]. Their distinct shape makes them distinguishable from their 
surroundings in the MR images. However, clinical applications of micron-sized magnetic 
particles are limited since both their size and the remanent magnetization once the magnetic field 
is removed would prevent to achieve the required colloidal stability.  
In a previous study we showed that a micron-sized agglomeration of superparamagnetic 
nanoparticles can resemble the effect of a microparticle in the form of a generated signal loss and 
can be detected and positioned in MR images [17]. We also investigated the limit of a 1.5 T 
scanner in detecting these micro-agglomerations. We showed that using a typical head receiver 
coil, agglomerations measuring 50 µm in diameter are detectable in the images of a clinical MR 
scanner (Figure 6-1). Furthermore, we reconstructed a 2D synthetic microvascular network 
through injection of micro-agglomerations of magnetite nanoparticles and tracked them in real-
time using a fast MR imaging sequence [18]. 
Our previous studies were limited to the reconstruction of a 2D model. In this paper, a method 
is proposed to expand the previous approach to allow the reconstruction of a 3D vascular network 
through the fast tracking of magnetic particles in MR images. Phantom experiments are used to 
validate the proposed technique in a 3D microvascular model.  
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6.3 Materials and Methods 
6.3.1 Simulation study 
The susceptibility artifact generated by the magnetic agents was simulated based on the echo 
shifting effect in gradient echo images caused by the phase accumulation at the echo time (TE). 
The measured signal in the presence of a background ΔB gradient in gradient recalled echo at 
position r!  is [19]: 
( ) ( ) ( ) dvertrS
v
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!!!! πγπγρ 22,          (Eq. 6-1) 
The proton density (ρ) was assumed to be constant. The major effect of the additional gradient 
is a phase shift in the spinning protons due to the term BTEΔ− πγ2 . ΔB is the field distribution 
induced by a magnetic particle that can be approximated by the magnetic field of a dipole at 
position r! : 
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where m!  is the magnetic moment of the particle. The presence of a background gradient is the 
source of two types of artifacts in MR images; echo shifting and geometrical distortion. The latter 
is reflected on the both gradient echo (GRE) and spin echo (SE) sequences. In our simulation 
model, the geometrical distortion was ignored due to its non significant effect for image 
resolutions higher than 200 µm [16]. 
The images were calculated for a coronal plane with a slice thickness of 5 mm and a pixel 
spacing of 0.5 mm. Echo time was set to 2.6 ms. Particles’ diameter was set to 150 µm. Based on 
the typical magnetization curve of Magnetite particles, it was assumed that the microparticles 
were saturated at the magnetic field strength of 1.5 T.  
A 3D vascular network was arbitrarily created using random spatial coordinates. The generated 
network fit in a field of view of 4×4×4 cm3 and included three levels of bifurcations and two 
branches at each bifurcation level (Figure 6-2C). A multi-slice multi-acquisition experiment was 
performed. 
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Six random coordinates were generated within the vascular network as the positions of the 
magnetic particles. According to the equations 1 and 2, the artifact volumes were simulated at the 
random generated coordinates in a 3D space. The volumes represented the magnetic field 
inhomogeneity caused by magnetic particles when subjected to B0. 
Subsequently, coronal slices spaced at 5 mm within the FOV were considered. The intersection 
of a slicing plane and 3D volume(s) correspond to the form of the artifact in MR images. A 
complete signal loss having the shape of a four-leaf-clover indicates the presence of a particle in 
the imaging plane. Figure 6-2A shows the particles randomly distributed over the vascular 
network and the intersection of a coronal slice within the vascular network. The form of the 
artifacts on the corresponding slice as they appear in MR images of a GRE sequence is shown in 
figure 6-2B. 
The position of the artifact reflects the exact position of the magnetic particles. Center Of 
Gravity (COG) is an estimate of the center of a moving object with a sub-pixel precision [20].The 
in-plane locations of the particles were determined based on the COG of the artifacts. The 
coordinates representing the particles’ positions were calculated based on the weighted average 
of the pixel’s position (Xk) in the field of view, whereas, the intensity of each pixel (Ik) was used 
as the weighting factor ( ∑∑
k
k
k
kk IIX ). The location of the slice including the artifact represents 
the position of the particle on the third dimension perpendicular to the imaging plane. The 
experiment was repeated 10 times and at each time the particles were randomly distributed within 
the vascular network (multi-acquisition). The particles at each acquisition were positioned 
through 8 slices within the FOV (multi-slice).  
The reconstructed points were compared with the generated vascular network to calculate the 
measurement error (Figure 6-2C). Figure 6-3 depicts a diagram of the steps performed by the 
algorithm. The mean measurement error on all axes was 0.425 ± 0.061 mm. It was found that the 
positioning error on the third dimension (axis perpendicular to the imaging slice) was nearly 
twice as high as on the imaging plane axes. The difference is due to the limitation in setting the 
slice thickness less than a certain limit as a result of a significant drop in the signal to noise ratio. 
The slice thickness is a trade-off between the imaging resolution and the signal to noise ratio.  
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6.3.2 Phantom experiments and results 
A 3D vascular network was fabricated from glass using the glassblowing technique. The outer 
and inner diameters of the channels were 4 and 2 mm, respectively. The vascular network was 
designed to have an inlet channel branching into eight smaller channels in a three-stage division. 
The dimension of the network was 7×7×3 cm3 (Figure 6-4).  
Nanometer-sized magnetic particles do not generate a distinct signal loss with an identified 
form (a four-leaf clover in coronal and sagittal planes and a circle in transversal planes) in MR 
images due to their low magnetic moments. In order for the nanoparticles to create sufficient 
disruption in the magnetic field and become detectable in MR images, micrometer-sized 
agglomerations (~200 µm) of Magnetite (Fe3O4) nanoparticles were generated. Iron-oxide 
nanoparticles are of great interests for MR imaging owing to their superior biocompatibility and 
greater sensitivity in nanomolar range compared to gadolinium complexes which make them 
interesting T2 contrast agents [21]. The surface of these particles can be modified by organic 
materials such as polymers for different treatments or prognosis applications [22].  
An oil-based ferrofluid (Ferrotec) solution made of Magnetite nanoparticles was used to 
generate small magnetic entities. The ferrofluid contained 10% Magnetite, 10% oil soluble 
dispersant and 80% oil-based carrier fluid. The magnetic moment of the particles was measured 
using a vibrating sample magnetometer (EV9, Microsense). The saturation magnetization was 
measured at 68 emu/g and the hysteresis curve confirmed that the particles were saturated at 1.5 
T. Ferrofluid droplets were generated through a T-junction geometry included at the entry of the 
network. Oil in water emulsion consists of oil phase droplets dispersed in an external aqueous 
continuous phase. The continuous phase consisted of water, Sodium Dodecyl Sulfate (SDS) (0.1 
wt %) to stabilize the formed droplets [23] and Glycerol (39 wt %) to mimic the blood viscosity 
[24]. The continuous phase was injected at 300µL/min using a syringe pump 
(Harvard Apparatus, Holliston, MA, model PHD 2000). The dispersed phase was injected 
through a plastic needle and a 1mL capacity syringe while the MRI sequence was running. The 
flow velocity in the 2 mm channels was at 0.21 cm/s. 
Imaging was performed using a 1.5 T scanner (Magnetom Avanto, Siemens, Erlangen, 
Germany) and an 8-channel standard head coil. The injected micro-agglomerations of Magnetite 
particles were tracked in real-time in the vascular network using a fast imaging sequence with 
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steady-state precession (True FISP). Parameters were set as: imaging matrix = 256×256, pixel 
spacing = 0.78×0.78 mm2, TR = 4.32 ms, TE = 2.16 ms, slice thickness = 3.6 mm, flip angle = 
70˚, number of slices = 17, number of measurements = 16. 
In order to compensate for the lack of resolution on the axis perpendicular to the imaging 
plane, observed in the simulation study, the experiment was performed twice for two different 
imaging planes: coronal and transversal. Considering the MRI’s world coordinate system, stacks 
of coronal and transversal images lack resolution on the y and z axis, respectively, for the 3D 
reconstruction of a vascular network. Addition of the coordinates obtained from the two stacks 
can complete the missing information.  
A T1- weighted GRE sequence (flash 3D) was performed to obtain a 3D representation of the 
vascular network to serve as the reference image. The 3D image was used to calculate the 
measurement error of the 3D reconstruction. The parameters of the sequence were set as follows: 
voxel dimension = 256×512×128, pixel spacing = 0.39 × 0.39 × 0.80 mm3, TR = 22 ms, TE = 9.2 
ms and flip angle = 30˚. 
The COGs of the artifacts were used to position the particles in each image. Figure 6-5A shows 
the susceptibility artifacts within multiple coronal slices at different time instants. Only a 
complete signal loss was considered to resemble the presence of a particle within a slice (Figure 
6-5B). The acquisition sequence was repeated 16 times and at each acquisition, 17 slices were 
imaged. The total duration of the scan was 165.92 s (0.61 s for each slice). 
All the extracted x, y and z coordinates were assembled to build up a 3D distribution of the 
artificial vascular network. Figure 6-6A shows the assembled data. At each segment, the points 
were fitted based on a 3D polynomial regression model. 
The bifurcation points in the vascular network were used as a baseline to align the 
reconstructed vascular network onto the 3D reference image through the application of a rigid-
body transformation (Figure 6-6B). The calculated points were compared with the centerline of 
the channels, extracted from the 3D reference image, to determine the absolute measurement 
error (xreal - xmeasured).  
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As shown in figure 6-7A, the vascular network was divided into 20 segments and the 
measurement errors were calculated separately for each segment. Figure 6-7B presents the 
average error at each segment. 
In the next step, a new set of coordinates using transversal images were calculated based on the 
above technique and were added to the coronal slices data. Figure 6-8 shows the combined 
imaging planes and 3D extracted coordinates. The combined extracted coordinates were 
assembled to build up a 3D distribution of the artificial vascular network. Figure 6-9A shows the 
fitted curves calculated based on two different datasets: 1) combined coronal and transversal data 
and 2) coronal data only. The root mean squared errors of the fits were calculated to be 0.35 mm 
for the combined data versus 0.76 mm for the coronal data. The average error at each segment 
was recalculated based on the combined data reconstruction (Figure 6-9B).  
6.4 Discussion and conclusion 
The results show that the positioning errors using the images of the coronal slices are relatively 
higher in some particular segments (number 7, 11 and 12). The distance between two adjacent 
slices is limited by the signal to noise ratio (SNR). In our experiment, the slice thickness was set 
to 3.5 mm. As mentioned earlier, only one complete signal loss is accounted for each ferrofluid 
droplet expected to be present within a slice. However, when a segment or a part of it lies 
between two adjacent slices (segments number 2, 7, 11 and 12), it becomes challenging to 
visually decide whether the signal loss is complete. In order to compensate for the lack of 
resolution on the axis perpendicular to the coronal plane, a combination of coordinates, extracted 
from coronal and transversal imaging slices, was used to build up the 3D vascular network. As it 
is shown in figures 6-7B and 6-9B, the combination of the coordinates led to a decrease in the 
mean measurement error at each segment. The decrease was more significant in the segments 
where a relatively high positioning error was observed using the coronal data only. The fitted 
data using a combination of the coronal and transversal data showed to have a higher goodness-
of-fit value than the ones using the coronal data only.  
The positioning error can also be reduced by the injection of uniform droplets of ferrofluid. In 
this case, prior to the experiment, a template of a complete signal loss shall be prepared based on 
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the dimension of the droplets. Accordingly, only the signal losses having a high correlation with 
the template are to be taken into account [25].  
We generated micron-sized drops of oil-based ferrofluid in water by injecting the ferrofluid in 
a water-based continuous flow in the presence of surfactant. Through their known shape of signal 
loss, ferrofluid drops were discreetly detectable in the images. Ferrofluid was hand-injected 
during the imaging sequence through a plastic needle. As a result, the generated drops were non-
uniform in size and the size of the artifacts varied in the images. Positioning precision is higher 
for smaller artifacts [26]. Therefore, the size of the particles is a trade-off between the visibility 
of the signal loss and the positioning accuracy.  
Balanced steady-state gradient recalled echo (True FISP) is a fast sequence that achieves a 
scanning time of ~0.5 s per image with a high SNR and a high sensitivity to field inhomogeneity. 
This sequence was exploited in our experiment as it has the highest specificity for detection of 
Magnetite particles as well as a high temporal resolution. Unlike GRE sequences, True FISP is 
not sensitive to the background field inhomogeneities induced by poor shimming, presence of 
blood, etc. This advantage of True FISP is owing to the refocusing of the background resulting in 
a SE- like insensitivity to the background gradient field inhomogeneity [27, 28]. 
In our previous study, dynamic tracking of the micro-agglomerations of Magnetite 
nanoparticles, measuring 10 ± 2 nm in diameter, was used to reconstruct a 2D vascular network 
of 150 µm in diameter [18]. Nevertheless, the glass blowing technique used did not support 3D 
fabrication of a vascular network at such similar scale and therefore, the proposed algorithm was 
validated in a 3D vascular network at an altered millimeter scale.  
Water in oil emulsions composed of iodized oil and an aqueous solution carrying anticancer 
medications are wildly used in the treatment of the hepatic tumors [29]. Oil-based ferrofluid has 
never been tested in-vivo as a contrast agent and its clinical applicability remains to be validated.  
SPIOs have several characteristics turning them to interesting contrast agents; they benefit 
from biocompatibility, they have a long circulating half-life and they are easily cleared from the 
blood circulation through the reticuloendothelial system [30]. However, they do not possess the 
highest saturation magnetization among the superpamagnetic nanoparticles. The size of the signal 
void created as a result of presence of a magnetic particle is directly proportional to the saturation 
magnetization of the particles. Iron-cobalt nanocrystals with graphitic carbon have the highest 
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magnetization among all magnetic materials making them an interesting alternative to SPIOs [9]. 
Owing to superior magnetic properties, the application of these particles to the proposed 
technique can lead to visualization of smaller vessels. Nevertheless, due to the easy oxidation and 
the potential toxicity, their clinical applications remain to be confirmed.  
In arterioles of 10 to 200 µm in diameter, blood velocity varies between 0.1 and 0.5 cm/s. We 
tried to reproduce a velocity of a similar magnitude in the channels (~0.21 cm/s). Form of the 
signal void derived from a moving particle at this relatively low velocity is not significantly 
altered. The blood velocity in the human body reaches 5 cm/s in small arteries and 10 cm/s in the 
larger ones. Shape of the signal loss obtained from a particle traveling at higher velocities could 
be completely distorted. In order to track the particles at the arterial level, the blood velocity can 
be reduced using a temporary balloon occlusion. 
In conclusion, a method for 3D reconstruction of a microvascular network using a clinical MR 
scanner, typical head coil and sequence parameters, was proposed. The technique was tested in a 
phantom model. It was shown that the elevated positioning error on the third dimension can be 
compensated by combining the reconstructed points generated by the scans of at least two 
different spatial planes. The results suggest that the method can be used for the reconstruction of 
vascular networks beyond the spatial resolution of the scanner.  
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Figure 6-1: Clinical MRI (left) and microscopic (right) images of a capillary with an inner 
diameter of 50 µm injected by agglomerations of Magnetite particles. 
A B
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Figure 6-2: Random distribution of the magnetic particles (circles) on the vascular network 
(dotted lines) and their intersection with a coronal slice (A), form of the artifacts on the 
corresponding slice as they appear in MR images of a GRE sequence (B). Reconstructed points 
(×) and the simulated vascular network using coronal slices (C). 
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Figure 6-3: Diagram of the steps performed in the simulation of a multi-slice, multi-acquisition 
MR imaging of a vascular network. 
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Figure 6-4: Experiments setup; suspended vascular network in a container filled with water and 
Sodium Chloride. The continuous phase (water, Glycerol and SDS) and ferrofluid are injected 
through the T-junction prior to the network’s inlet. 
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Figure 6-5: Susceptibility artifacts within multiple coronal slices at different time instants with 
the following imaging parameters: imaging matrix= 256×256, pixel spacing= 0.7813×0.7813 
mm2, TR = 4.32 ms, TE = 2.16 ms, slice thickness = 3.6 mm, and flip angle = 70˚ (A). Complete 
signal losses (circled artifacts) were considered to resemble the presence of a particle within the 
imaging slice (B). 
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Figure 6-6: 3D reconstructed points (●) through the localization of the micro-agglomerations 
of Magnetite particles at 16 different acquisitions and 17 different slices. The points at each 
segment were fitted (solid line) based on a polynomial regression model in three dimensions (A). 
The measured points (●) superposed over the 3D reference image obtained from a 3D scan with 
the following parameters: Imaging volume = 256×512×128, pixel spacing = 0.39×0.39×0.80 
mm3, TR = 22 ms, TE = 9.2 ms and flip angle = 30˚ (B). 
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Figure 6-7: The distribution of the segment numbers and how the network is positioned in 
relation to the imaging coronal planes (A). Mean measurement error and the standard deviation 
for each segment based on coronal planes data (B). 
A
B
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Figure 6-8: Combined imaging planes and 3D coordinates extracted from coronal and 
transversal imaging planes.  
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Figure 6-9: The coronal data (black) and the combined coronal-transversal data (gray) were 
fitted at each segment based on a polynomial regression model in three dimensions (A). Mean 
measurement error and the standard deviation for each segment based on the combined coronal-
transversal data (B). 
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CHAPTER 7 COMPLEMENTARY RESULTS 
Phantom experiments required the utilization of microfluidic channels mimicking the 
microvascular networks. Contrast agents (ferrofluid droplets) were also developed using a T-
junction microfluidic device. The combination created an integrated microfluidic device 
including a vascular network, a T-junction geometry and a tortuous reservoir to collect the 
generated droplets. The integrated microfluidic device was fabricated on Plexiglas using a micro-
milling machine. This chapter presents details of the fabrication process. 
7.1 Fabrication of microchannels  
The experimental vascular networks were fabricated on Plexiglas (PMMA) using a circuit-
board plotter machine (LPKF Protomat 95S/II) and a multi press machine (LPKF Multipress II) 
for high pressure thermal sealing.  
The vascular network’s map was designed and plotted using LPKF CircuitCAM PCB software 
(Figure 7-1). The software is used for creating the design data required for the LPKF milling 
machine. The output is an LMD file, readable by the LPKF PCB machine.  
 
Figure 7-1: The design of the vascular in the CircuitCAM software. 
 
The constituent segments of the pattern were milled. The mills were automatically selected by 
the machine according to the size of the channels defined in the plot. A PMMA top layer 
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including built-in holes was used to seal the milled PMMA layer. Once the two PMMA pieces 
were aligned, a press machine was used to assemble and seal the contact area (Figure 7-2). The 
temperature and the pressure were set to 105˚C (glass transition temperature of PMMA) and 140 
N/cm2, respectively. Total duration of the cure was 60 min.  
 
Figure 7-2: The final milled PMMA sealed in the press machine. 
 
7.2 Formation of microagglomerations through a T-junction 
geometry 
A T-junction geometry was integrated in the design to generate droplets of oil-based ferrofluid 
in water. Successful generation of the droplets and fluidity of their movement in the channels 
depend on the wetting property of the channels’ surface (Figure 7-3). 
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Figure 7-3: Formation of undefined oil droplets in water in a T-junction geometry with 
hydrophilic channels.  
 
PMMA’s surface is highly hydrophobic. However, formation of unconfined oil-in-water 
droplets necessitates a hydrophilic surface. In order to inverse the wetting property of the 
PMMA, surface of the channels as well as their mirror pattern on the top layer were coated by 
Silicon dioxide, also known as Silica (SiO2) (Figure 7-4). Silica has a high hydrophilic 
characteristic. A thin layer of Silica (~ 50 nm) was deposited using a Boxer coating system 
(Leybold Optics).  
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Figure 7-4: Impact of silica coated PMMA on the wetting property of the surface. 
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In order to coat the channels’ surface solely and avoid the negative impact on the assembly of 
the top and bottom layers, prior to the coating process a protection mask was laid on both PMMA 
layers. The protection mask was as well a PMMA based layer fabricated by the PCB machine 
(Figures 7-5 and 7-6). They were removed after the silica treatment process.  
 
Figure 7-5: A milled PMMA and its mask to exclusively expose channels to the Silica 
treatment. 
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Figure 7-6: A milled PMMA with exposed channels’ surface prior to Silica coating.  
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CHAPTER 8 GENERAL DISCUSSION 
MRI is a versatile imaging modality that allows for 3D assessments of tissue morphology, 
metabolism and physiology. The recent advances in the MRI technology including creation of 
more powerful gradient systems, advanced receiver coils and development of new contrast agents 
has led to faster image acquisitions with higher resolution and sensitivity. In this study, we 
present the application of micron-sized agglomerations of iron-oxide nanoparticles in the 
visualization of microvessels. We studied behaviors of the susceptibility artifact in the images 
acquired by the clinical MR scanners 
In previous studies pre-clinical scanners were used to detect single particles (~ 1µm in 
diameter) for cellular and molecular imaging purposes [108, 109, 113, 114]. Recognition of 
signal cells using a 1.5 T scanner has been reported through the application of custom-built 
solenoidal RF coils and/or custom gradient coils with an inner diameter of 11 cm and a maximum 
gradient of 600 mT/m [115]. However, such instrumentations cannot be used for clinical 
applications. In-vivo visualization of single cells at 1.5 T can also be achieved by using high-
temperature superconducting surface coils measuring 12 mm in size. Such RF coils produce 
images with a very limited FOV (~ 1 cm2) [101]. Therefore, lack of spatial resolution and/or 
penetration depth limits the application of clinical scanners in detection of magnetic 
microparticles in the human’s organs. We performed our studies using a 1.5 T MR scanner and a 
commercial head coil. The images were acquired over a rather large FOV. It was confirmed that a 
15 µm particle and a 50 µm agglomeration of iron-oxide nanoparticles is visible using a fast 
steady state sequence acquired from a clinical 1.5 T MR scanner (TrueFISP). We proposed real-
time tracking of the magnetic particles to obtain their travel trajectory through a fast imaging 
sequence. Assembling all the trajectories allowed for the reconstruction of the local 
microvasculature which is a complementary step in the MRN.  
 In our preliminary study (Appendix A) it was shown that a single 15 µm ferromagnetic 
particle is visible in the GRE images of a clinical MR scanner. However, the remanent 
magnetization of the ferromagnetic particles once exposed to a magnetic field prevents their 
application as contrast agents in the MRI. Moreover, their rather large size is a limiting factor in 
clearance from the body. On the other hand, owing to the macrophage process in the 
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reticuloendothelial system, superparamagnetic nanoparticles are easily cleared from the body. 
Furthermore, they do not retain any net magnetization upon removal from the magnetic field 
[31]. These characteristics along with their strong effect on the proton’s relaxation time make 
them interesting contrast agents for the clinical applications. 
Sensitivity of a clinical scanner is not sufficient to detect a single superparamagnetic particle. 
However, an assembly of such particles can be detected by a clinical scanner. An agglomeration 
of iron-oxide (Fe3O4) nanoparticles measuring 50 µm in diameter was visible in the images 
acquired by a fast susceptibility-sensitive MR sequence [116].  
8.1 Agglomeration of iron-oxide nanoparticles 
A microfluidic T-junction geometry was used to generate microagglomerations of 
nanoparticles required for the imaging experiment. The technique has previously been presented 
in [117-122]. Oil-in-water droplets have been generated through different microfluidic-based 
geometries. However, the presence of magnetic nanoparticles in the oil-based ferrofluid, creates 
limitations in the application of certain techniques.  
An assembly of superparamagnetic nanoparticles measuring in the range of 50 µm to 200 µm 
cannot be obtained from the commercial market. Hence, we assessed the behavior of such 
particles when used for the visualization of microvessels by using an oil-based ferrofluid 
composed of iron-oxide nanoparticles. Although water-in-oil emulsions composed of iodized oil 
carrying anti-cancer drugs is used in the treatment of the hepatic tumors [123], oil-based 
ferrofluid has never been used clinically as a contrast agent. Therefore, the clinical application of 
such particles shall be subject to further studies.  
This contrast micro agent generating technique was used due to several advantages and 
conveniences; 1) availability of oil-based or water-based ferrofluids at a low cost, 2) ease of 
injection, 3) accessibility to a PCB machine, 4) uniformity and monodispersity of the droplets 
generated and 5) an easy control over the particles’ size and their spacing. 
The stability of droplets’ formation highly depends on the interfacial tension between the 
continuous phase and the microchannels’ wall. Stable generation of droplets is feasible only if the 
continuous phase wets the channels’ wall thoroughly, while the dispersed phase does not wet 
them at all. In our model, the continuous phase is water and the fluid to be dispersed is oil-based 
  
 
 
112 
ferrofluid. Since the PMMA is highly hydrophobic, formation of stable oil-in-water droplets was 
not possible. Several techniques have been developed to inverse the wetting property of the 
materials. Exposure to oxygen plasma effectively increases the surface energy of the material 
resulting in a surface that is hydrophilic. However, this effect is temporary and, due to the contact 
of the treated surface to the air, it only lasts for few hours [124, 125]. Addition of a surfactant, 
such as SDS, into the water phase is another technique to change the wetting property of the 
channels’ wall. Water absorbs the surfactant’s polar head and, as the result, their tail is oriented 
towards the wall. This orientation changes the wetting property of the wall [120]. Yet, this 
technique failed in our experiments as it did not create the stability required for generating the 
oil-based ferrofluid drops in water.  
Hybrid coatings containing Silica and PMMA are applied to protect metallic surfaces from 
corrosion [126]. Other effects on the surface are thermal stability, mechanical strength and 
wettability. Channels made of glass or Silicon are inherently hydrophilic making them an ideal 
tool for the generation of oil-in-water drops [127].  
We applied Silica coating on the PMMA surface to inverse its wetting property from 
hydrophobic to hydrophilic. Creation of hydrophilic channel walls allowed for formation of 
unconfined stable ferrofluid droplets in water and as well alleviated a friction-free movement of 
the ferrofluid droplets in the microvascular channel.  
Various microfluidic geometries are used for the formation of droplets. T-junctions are one of 
the most frequently used geometries. Size of the produced droplets and their spacing depend on: 
1) the flow rates of the continuous and the dispersed phases, 2) the concentration of the surfactant 
and 3) the internal diameter of the channels. In order to achieve smaller drops we used a micro 
liter syringe and a needle with an internal diameter of 100 µm. In the MR imaging, a minimum 
distance between the droplets should be maintained so that the susceptibility effects of the 
individual droplets do not interfere. The spacing becomes larger as the flow rate of the 
continuous phase increases relative to that of the dispersed phase.  
Furthermore, due to the magnetic force exerted on the magnetic volumes, presence of a 
magnetic field disrupts the formation of ferrofluid drops. As such, all the drops were generated 
outside of the MRI room and were collected in a tortuous reservoir built in the microfluidic 
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device next to the T-junction. The droplets were propelled inside the vascular network during the 
imaging sequence.  
In conclusion, the application of a T-junction hydrophilic geometry together with a built-in 
reservoir was found to be an effective method for generating stable isolated oil-based ferrofluid 
drops. 
8.2 Iron-oxide nanoparticles as positive contrast agents 
Iron-oxide nanoparticles are extensively used in MRI as negative contrast agents for different 
applications such as angiography, cell labeling and tracking [22, 24, 28, 35, 47]. In the presence 
of B0, the nanoparticles induce inhomogeneities in the local magnetic field. This effect results in 
shortening of T2 relaxation time of the protons and darkening of the MR images.  
In our study, we applied a real-time tracking of the magnetic microparticles (micron-sized 
agglomerations of nanoparticles) as they were released in a vascular network to identify their 
trajectory path. The signal voids arising from the distortions in the T2*-weighted GRE images 
represent the presence and the position of the particles. They are found to be the most effective 
way to enhance the effect of a microparticle, the size of which is significantly inferior to the 
spatial resolution of the system. However, the signal voids result in an undesirable negative 
contrast, causing tissues with a low proton density to mask the particles. As a result, the magnetic 
microparticles cannot be distinguished from a void in the image. 
It is possible to achieve positive contrast with superparamagnetic nanoparticles by employing 
T1 weighting [128]. However, due to the predominant T2 and spin dephasing effects of the 
magnetic nanoparticles, in detecting magnetic nanoparticles the T1-weighted images are not as 
sensitive as the T2-weighted counterparts [129]. Therefore, it is of a great interest to acquire T2-
weighted positive contrast images in the tissues containing superparamagnetic nanoparticles.  
A variety of sequence modification-base techniques have been developed for positive contrast 
imaging of iron oxide nanoparticles, applying to cell tracking or real-time visualization of devices 
in interventional MRI. The main class of sequences are 1) frequency selective excitation [130], 2) 
gradient sensitive sequences [131], and 3) steady state free precession techniques [132].  
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In a recent study by [133], a novel and fast positive contrast technique, employing a balanced 
steady state pulse sequence, was presented and successfully implemented in an in-vivo cell 
detection experiment on a clinical MRI platform. Such applications of the steady state pulse 
sequence support the feasibility of an in-vivo application of our proposed technique. 
  
8.3 Real-time imaging of magnetic particles 
The fact that 180˚ pulses do not exist in the gradient echo sequences implies that T2* effects are 
not reversed during the sequence and as a result, compared to the SE techniques, the GRE 
sequences are more sensitive to the magnetic susceptibility effects. Detection of 
superparamagnetic iron-oxide particles has been accomplished through T1 [134], T2 [135] and 
T2*-weighted images [136, 137]. T2*-weighted GRE acquisitions provide the highest sensitivity to 
the presence of a superparamagnetic magnetic particle. However, their sensitivity is equally high 
to the other sources of susceptibility such as hemorrhage or tissue-air interfaces. This makes them 
less specific in the detection of iron-oxide nanoparticles. Contrarily, T1 and T2-weighted imaging 
are less sensitive and more specific in the detection of iron-oxide nanoparticles. This is due to the 
refocusing of the background field inhomogeneities through the SE acquisitions.  
The balanced steady state free precession technique, known as True-FISP, has shown to 
provide the highest sensitivity to the presence of  iron-oxide nanoparticles [33, 115] whereas it is 
not sensitive to the background inhomogeneities.  [67]. The short repetition times (much smaller 
than T1 and T2 relaxation times) in the True-FISP sequence allows to obtain an acquisition time 
of ~ 0.5 s per slice in real-time MR imaging [138, 139]. Therefore, True-FISP acquisition was 
our method of choice in the identification of magnetic particles in real-time. However, the 
sequence shall be modified to provide positive contrasts for the in-vivo applications. 
8.4 Accuracy of the proposed technique 
In a recent study [140], the total spectrum of the human hepatic vasculature, covering the 
macro- down to the microcirculation, was visualized and reconstructed in 3D through vascular 
corrosion casting and micro-CT scanning. Although, results were based on the scans of a single 
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liver, the detailed 3D data gathered gives an insight into the liver morphology including the mean 
radius and length as well as the estimated number of vessels per generation.  
At the macrocirculation level, mean radii vary from 13 mm to 1 mm. At the microcirculation 
level, mean radii and the mean length of the hepatic artery vary in the range of 80 to 800 µm and 
0.7 to 54 mm, respectively. At the capillary level (mean radii smaller than 40µm), the vascular 
network becomes highly interconnected and intertwined and thus a 3D illustration will only be 
possible through microscopic techniques and over a very limited region. 
In chapters 4 and 5, we showed the possibility of visualization of small microagglomerations 
reaching 50 µm in diameter with an accuracy of approximately half the size of a pixel (the 
positioning error decreases as the spatial resolution increases). Therefore, the identification of 
multiple agglomerations in a single voxel poses a particular challenge in the proposed technique. 
We calculated the artifacts’ center of mass to determine the position of the particles. This 
technique yields an estimate of the particle’s position with sub-pixel accuracy. On the other hand, 
new advanced mathematical models have been used to develop techniques for improving the 
precision in particle positioning and measuring the displacement of a moving mass [141-144]. 
Application of such techniques in enhancing the positioning accuracy is subject to further studies.  
In chapter 6, we showed the feasibility of 3D reconstruction of a vascular network through our 
proposed technique. The positioning error was found to be significantly larger on the axis that is 
perpendicular to the imaging plane. This difference arises from the imaging limitation in setting 
the slice thickness. Decreasing the slice thickness results in a significant drop in the signal to 
noise ratio. In order to compensate for a relatively high positioning error on the third dimension, 
we proposed to combine the reconstructed points generated by the scans of at least two different 
spatial planes. If the images of a 3D vascular network are acquired using a particular imaging 
plane, information relating to the parts of the network located between the two adjacent slices 
will be missed. The missing data can be compensated by adding the coordinates obtained from 
the images of other spatial planes. 
In our proposed technique, delineation of the vessels necessitates; 1) a sensitive imaging 
sequence to detect small quantities of nanoparticles and 2) an adequate number of agglomerations 
to be injected in the vascular network so that the initial dispersed reconstructed points turn to a 
pattern illustrating the vascular network. Number of the agglomerations to be injected may be 
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obtained in advance through a simulation study. Information of the local vasculature where the 
imaging is performed will be the necessary inputs for the simulation study. This includes the 
mean radius, the mean length, the estimated number of vessels per generation as well as the 
imaging parameters. 
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CHAPTER 9 CONCLUSION AND RECOMMENDATIONS 
This project aimed to develop a new technique for visualization of human microvasculatures 
not visible using the current clinical imaging modalities and is a complementary step in the 
MRN-assisted chemoembolization intervention [12, 13]. Our objective was to find a 3D 
representation of the local vascular network leading to a tumor site, which can subsequently be 
used for the navigation of therapeutic magnetic carriers. Our visualization technique was 
developed based on the magnetic particles’ effect on the homogeneous magnetic field of a 
clinical MRI system.  
Initially, behavior of the magnetic particles of different sizes and magnetic domains in the 
presence of MRI’s magnetic field was studied through simulation and phantom experiments. 
Subsequently, capacity of the clinical scanners in detecting magnetic particles was evaluated. 
These gave an insight into the potentials and the limitations of the proposed technique 
(Appendices A and B and chapter 4). They helped achieve the first two objectives of the project, 
defined in chapter 3.  
Thereafter, an algorithm was proposed for 3D reconstruction of an unknown vascular network. 
The algorithm was based on susceptibility effect of the magnetic nanoparticles and their real-time 
MR tracking. The proposed algorithm was assessed through 2D visualization of a micrometric 
vascular network using magnetic agglomerations. The results suggested that the technique could 
be used to reconstruct a micrometric vascular tree beyond the spatial resolution of the system, 
with a measured average error of approximately half of a pixel’s size (chapter 5). The experiment 
was carried out using a 1.5T MR scanner, a standard head coil and typical imaging parameters 
over a 16×16 cm2 FOV.  
Conclusively, the proposed technique was studied in a 3D model (chapter 6). The technique 
was tested in a phantom model. It was confirmed that the method could be used for 
reconstruction of a vascular network using a clinical scanner at the subpixel accuracy. A new 
technique in the generation of stable micron-sized agglomerations of nanoparticles using a 
microfluidic device was developed and presented in chapter 7. 
In-vivo realization of the proposed technique necessitates further steps:  
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• The sequence of choice (True-FISP) should be modified to yield positive contrast imaging of 
the iron oxide nanoparticles [132], 
• A simulation method should be developed to determine the number of the 
microagglomerations necessary to visualize a vascular network and also the amount of the 
required magnetic nanoparticles, 
• The localization technique may be improved by applying a new mathematical model for 
positioning of moving masses through real-time images [141, 143], 
• Soft tissue and motion artifacts should be assessed and compensated, 
• Novel image reconstruction techniques, such as compressed sensing, may be applied to 
reduce the acquisition time per slice [139, 145, 146].  
The clinical application of the proposed technique will result in:  
• Decreasing the amount of antitumor drug, 
• Reducing the side effects of chemo-therapy, 
• Reducing the risk of tumor reformation, and 
• Reducing the risk of tumor metastases to other organs of the body. 
The results outlined can improve treatment of cancer significantly and reduce the costs 
incurred to the patients. It will have an impact on life expectancy of the patients fighting with 
cancer and as well, improve their quality of life during the treatment. 
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APPENDIX A – VISIBILITY OF MAGNETIC MICROPARICLES IN CLINICAL 
MR IMAGES 
 
Ferromagnetic materials have a rather high susceptibility. Magnetic susceptibility is a 
dimensionless quantitative measure of the degree of a material’s ability to induce a local 
magnetic field inhomogeneity within an applied homogeneous magnetic field. The induced 
magnetic field inhomogeneity from a small object can be approximated by the magnetic fields of 
a dipole:  
( )
⎟
⎠
⎞
⎜
⎝
⎛ −+= 35
0
0
ˆ.3
4
ˆ)(
r
m
r
rrmzBrB
!!!
!!
π
µ           (1) 
where µo=4π×10-7 is the permeability of the free space, rˆ  is the r-directional unit vector, zˆ  is the 
unit vector in z-direction, B0 is the external uniform magnetic field and 𝑚 is the magnetic dipole 
moment calculated by: 
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 where M!"#and a correspond to the saturation magnetization and the radius of the sphere, 
respectively. The local field inhomogeneity leads to: a) signal loss as the result of the intravoxel 
dephasing and b) position shift caused by the wrong frequency encoding according to Larmor 
frequency: 
( ) ( )rBr z
!!!
γω =          (3) 
where γ is the gyromagnetic ratio (42.576 MHz T-1) for protons. For the intravoxel dephasing, 
the average signal (s) over the slice selection can be written as Fourier transform of the spin 
density (ρ), given by: 
( )∫ −= dzezyxs iϕρ ,,  with TErBz )(
!!
γϕ =          (4) 
where φ is the phase dispersion across the voxel and TE is the echo time. The intravoxel 
dephasing creates an intensity distortion in the MR image, in the form of a signal loss (Sloss).              
Due to the 180° refocusing pulse, the dephasing effect is compensated in the SE sequence while 
it is well presented in the GE sequence. On the other hand, the wrong frequency encoding is 
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followed by a geometrical distortion the degree of which is determined by the local field 
inhomogeneity and the readout gradient strength. The position error due to geometrical distortion 
is calculated by: 
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+=ʹ′          (5) 
where x is the readout direction, x’ is the position generated from the MRI data and GR in the 
strength of the readout direction.  
 Simulations were performed to systematically investigate the pattern and the amount of the 
susceptibility artifact under varying values of the TE, the diameter of the microsphere and the 
field strength. The susceptibility artifact was simulated based on the intravoxel dephasing by the 
phase accumulation at the TE (see Eq. (4)) using MATLAB® programming language.  
Phantom experiments were carried out using three isolated stainless steel spheres (Salem 
specialty Ball Co., Inc.) measured 40, 20 and 15 µm in diameter and a saturation magnetization 
of 207 emu g-1. A single microsphere for each of the mentioned sizes was isolated under 
microscope and it was suspended in the middle of a solution made up of gelatin and Sodium 
Chloride to mimic the human body relaxation times. Imaging was performed using 1.5T 
(Magnetom Siemens) and 3T (Acheiva Philips) MRI systems.  
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Experimental observations of Sloss (summing the in plane signal loss over the region of interest) 
as a function of TE on the coronal plane using external field strengths of 3T (a) and 1.5 T (b) for -
♦- 40 µm, -■- 20 µm and -▲-15 µm stain less steel microspheres: 
 
 
 
 
 
 
 
 
  
 
 
135 
  Experimental coronal images of the stain less steel microparticles sized 15 µm (left), 20 µm 
(middle) and 40 µm (right) in diameter, imaged by a 1.5 T and a 3 T scanners with a TE= 5 ms 
(a), TE= 20 ms (b) and TE = 30 ms (c). Right: Simulated coronal images of the stain less steel 
microparticles sized 15 µm (left), 20 µm (middle) and 40 µm (right) in diameter, with the 
following scan parameters: B0= 1.5 T and B0=3 T, TE= 5 ms (a), TE= 20 ms (b) and TE = 30 ms 
(c): 
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Amplification factors according to the scanner’s magnetic field strength and the TE. The 
measured and the simulated results are shown in transversal and coronal planes: 
 
Depending on the TE values, the amplification factors vary in the ranges of 75 to 146 for the 
3T MRI scanner and 72 to 135 for the 1.5T MRI scanner (Table 1). The simulation results and 
the in vitro measurements were compared using the paired Student’s t-test with statistical 
significance defined for probability values less than 5%. The results showed no significant 
difference between the two observations with p = 0.075 and p = 0.054 for the 1.5 T and 3T 
scanners’ results, respectively. 
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APPENDIX B – POSITIONING OF MAGNETIC MICROPARTICLES USING 
SUSCEPTIBILITY ARTIFACTS 
Ferromagnetic materials induce a distorted region in MR images due to the field 
inhomogeneties caused by their high magnetic susceptibility. The field induced by sphere 
magnetic particles can be approximated by that of a dipole. 
The susceptibility difference is the source of two types of artifact in MR images; geometrical 
distortion and echo shifting. Geometrical distortion is any misregistration of spin positions 
caused by field variations during frequency encoding [50, 58, 147]. If G' represents the static 
background gradient created by field inhomogeneties, spins residing at position x will be mapped 
to position x': 
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Background gradient along the phase encoding direction (perpendicular to the readout 
direction) imposes a distortion on the voxel shape. Image distortion is reflected on both the 
gradient echo sequence (GE) and the spin echo sequence (SE). On the other hand, due to the 180° 
refocusing pulse of the SE sequences, the echo shifting effect only appears in GE images. The 
influence of a position dependent phase term is added to that of the unusual scaling of the k-space 
variable (as in SE) to determine the position of the spins: 
( ) xTEGx xʹ′−= πγϕ 2          (2) 
When the phase dispersion is a nonzero positive integer multiple of 2π, the voxel signal 
vanishes completely. Therefore, echo shifting creates a signal loss in MR images. GE images are 
affected by both forms of artifacts; however echo shifting has a dominant effect on the 
geometrical distortion in GE scans. In [148], two different image simulations have been 
compared: a) based on geometrical distortion and phase dispersion and b) based on phase 
dispersion only. Significant deviations have been observed in the results obtained for high 
resolution images (< 100 µm) produced in high field MRI scanners. Nevertheless, for image 
resolutions of > 200 µm (clinical MR scanners) the difference has not been significant.  
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Total signal loss in GE imaging is expected to be independent of the in-plane resolution and 
the geometrical distortion [149]. Moreover, the position of the artifact is expected to reflect the 
exact position of the microparticle. 
For intravoxel dephasing, the measured signal within the volume of interest in GE imaging and 
with a homogeneous  
spin density (ρ) is described by: 
( ) ( )( )dvtritS
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ϕρ          (3) 
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!
γϕ =          (4) 
where φ is the phase dispersion across the voxel, TE is the echo time and γ is the gyromagnetic 
ratio for protons. The field distribution induced by ferromagnetic objects at position r!  varies as 
[147]: 
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where m! is the net dipole moment, N is the number of the particles within the field of view 
(FOV), D is the diameter of the particles and 
satM
!  is the magnetization saturation of the particles. 
The normalized signal is given by: 
( )( )∫ Δ−=
v
z dvTErBis
s !exp
0
ρ          (6) 
The susceptibility artifact of particles was simulated using MATLAB® programming language 
and based on the intravoxel dephasing caused by the phase accumulation at the TE in the GE scan 
(see equation (6)). The area of the Sloss was calculated by summing the in plane signal loss over 
the region of interest. Different distances and angles between microparticles were simulated to 
study the pattern of the artifacts and the minimum distance required to see them distinguishably. 
The images were evaluated for a coronal plane with a slice thickness of 3.5 mm and a pixel 
spacing of 0.5 mm. It was assumed that the microparticles are saturated at the magnetic field 
strength of 1.5 T.  
Phantom experiments were carried out using chrome-steel microspheres (Salem specialty Ball 
Co., Inc.) measured 0.4 mm and 0.8 mm in diameter and a saturation magnetization of ~1.3×106 
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A/m. Pairs of particles at distances set to different multiples of their diameters (15×D, 30×D, 
40×D and 80×D) were fixed on plastic plates.  
Simulated GE signal intensity as a function of the distance between the particles on the coronal 
plane with the following scan parameters: B0=1.5T, in-plane resolution = 0.5×0.5 mm2 and 
TE=10ms: The distance is labeled by multiples of the particles’ diameter (D). Curve labels 
indicate the diameter of the particles in micrometer. 
 
 
 
The distance is labeled by multiples of the particles’ diameter (D). Curve labels indicate the 
diameter of the particles in micrometer. 
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GE simulated signal of the micropaticles measured 40 µm in diameter with the following scan 
parameters: B0=1.5T, TE=10ms, in-plane resolution = 0.4×0.4 mm2 distances at 15×D (a), 25×D 
(b) and 40×D (c): 
 
 
Each pair of the particles were distanced and angulated according to the plot d. The centers of 
the artifacts (1) and (2) were used to calculate the distance and the angle between the particles 
(e). 
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GE simulated signal of the micropaticles measured 20 µm in diameter using the following scan 
parameters: B0=1.5T, TE=10ms, in-plane resolution = 0.2×0.2 mm2 (a) and 0.5×0.5 mm2 (b): 
 
 
The particles are distributed according to the plot c. Circled regions show particle pairs with 
different spacing. Region A presents two particles distanced within 15×D and 40×D. Region B 
and C present two particles distanced at 40×D and smaller than 15×D, respectively. 
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 Experimental (odd rows) and simulated (even rows) coronal images of 0.4 mm and 0.8 mm 
chrome-steel microspheres; (a) a single microparticle and (b) to (e) pairs distanced at 15×D, 
30×D, 40×D and 80×D respectively:  
 
 
 
Identical scan parameters were B0=1.5T, in plane resolution 0.6×0.6 mm2 and TE=10 ms. 
 
 
 
 
 
a b c d e 
